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ABSTRACT 
The ATP-binding cassette (ABC) transporter of mitochondria (Atm1) mediates iron homeostasis in 
eukaryotes, while the prokaryotic homolog from Novosphingobium aromaticivorans (NaAtm1) can 
export glutathione derivatives and confer protection against heavy metal toxicity. To establish the 
structural framework underlying the NaAtm1 transport mechanism, we determined eight structures 
by X-ray crystallography and single particle cryo-EM in distinct conformational states, stabilized by 
individual disulfide crosslinks and nucleotides. As NaAtm1 progresses through the transport cycle, 
conformational changes in transmembrane helix 6 (TM6) alter the glutathione binding site and the 
associated substrate binding cavity. Significantly, kinking of TM6 in the post-ATP hydrolysis state 
stabilized by MgADPVO4 eliminates this cavity, precluding uptake of glutathione derivatives. The 
presence of this cavity during the transition from the inward-facing to outward-facing 
conformational states, and its absence in the reverse direction, thereby provides an elegant and 
conceptually simple mechanism for enforcing the export directionality of transport by NaAtm1. One 
of the disulfide crosslinked NaAtm1 variants characterized in this work retains significant 
glutathione transport activity, suggesting ATP hydrolysis and substrate transport by Atm1 may 
involve a limited set of conformational states with minimal separation of the nucleotide binding 
domains in the inward-facing conformation.  
 
The ATPase kinetic data was fit to a non-essential activator model with expansion to two substrate 
binding sites. While the structural data suggests that MgATP and GSSG bind to distinct states, 
outward- and inward-facing conformations, respectively, and hence might be expected to exhibit 
negative cooperativity, the kinetic data support a more complex interplay and also the importance of 
lipid molecule presence. How GSSG binding stimulates ATPase activity remains an open question 
and highlights the importance of the still elusive ternary complex with both MgATP and GSSG 
bound to NaAtm1. 
 
Besides the structural and functional characterizations of the ABC exporter, NaAtm1, we 
additionally determined crystal structures of the repurposed periplasmic binding protein (PBP) from 
the ABC importer system. These PBPs are designed with circularly permutated GFP to act as 
 vi 
biosensors to sense the concentrations of smoking cessation drugs and neurotransmitters under 
cellular conditions. The crystal structures determined for the nicotine and acetylcholine biosensors 
not only revealed the key residues in ligand binding, but also demonstrated similar ligand induced 
conformational changes as seen in other PBPs by following the Venus-flytrap mechanism. 
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C h a p t e r  1  
INTRODUCTION 
1.1 ATP-Binding Cassette (ABC) Transporter Overview 
ABC transporters were first identified in bacterial uptake systems in the 1970s during the 
examination of energy coupling for amino acid transport (Berger and Heppel 1974). Later studies on 
different bacterial systems revealed a family of proteins that have highly homologous ATP-binding 
subunits (Higgins et al. 1986). Studies at the time on P (permeability)-glycoprotein (Pgp/ABCB1) 
also revealed that it contained similar nucleotide-binding domains as the bacterial ATP-binding 
subunits in nutrient uptake, suggestive of a common evolutionary ancestor (Chen et al. 1986). The 
name “ATP-Binding Cassette (ABC) transporters” was later acquired during the prediction of the 
tertiary structure for the nucleotide binding domain (NBD) of those bacterial uptake systems, and 
the eukaryotic multidrug transporter P-glycoprotein and CFTR (cystic fibrosis transmembrane 
conductance regulator) (Hyde et al. 1990). By then, it was known that ABC transporters are 
membrane transport proteins that are ubiquitously present in all domains of life with important roles 
in the translocation of a variety of substrates through coupling to the binding and hydrolysis of ATP 
(Higgins 1992).  
 
Among ABC transporters, the ABC importers are present only in prokaryotes and they are involved 
in importing ions, amino acids, and nutrients, such as iron, molybdate, methionine, arabinose, 
vitamin B12, etc. In contrast, ABC exporters are not only present in prokaryotes; they are also found 
in eukaryotes. The exporters are associated with key roles in multidrug resistance, fatty acid 
trafficking and mitochondrial iron homeostasis by exporting toxic substances and large 
macromolecules to the outside of the cell or a cellular compartment (Higgins 1992, Biemans-
Oldehinkel, Doeven, and Poolman 2006, Davidson et al. 2008, Rees, Johnson, and Lewinson 2009, 
Theodoulou and Kerr 2015, Locher 2016). 
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Despite the different transport directionalities between importers and exporters, they share the same 
characteristic core domains, including two variable transmembrane domains (TMDs) embedded in 
the lipid bilayer that provides the translocation pathway and sometimes the substrate binding sites 
for exporters, and two highly conserved soluble nucleotide-binding domains (NBDs) located on the 
inside of the cell or compartment, providing the binding sites for ATP (Figure 1a). The catalytic 
domain of the conserved NBDs consists of a conserved P-loop, also known as the Walker-A motif 
(GxxxxGK(S/T), where x is any residue), associated with the stabilization of the phosphate group 
during ATP binding; a Walker-B motif (hhhhDE, where h is a hydrophobic residue), providing a 
glutamate residue for catalyzing the hydrolysis of ATP; an H-motif providing a histidine residue to 
stabilize the transition state for ATP hydrolysis; an aromatic residue in A-loop that stabilizes the 
adenine ring of bound ATP; and an ABC signature motif (LSGGQ) that, together with its dimeric 
NBD counterpart, is important in binding ATP (Figure 1b) (Rees, Johnson, and Lewinson 2009, 
Locher 2016). Besides the core domains, the ABC importer systems have additional periplasmic 
binding proteins that are essential for substrate delivery to the cognate transporter, as well as 
additional cytoplasmic regulatory domains (Biemans-Oldehinkel, Doeven, and Poolman 2006, 
Davidson et al. 2008, Rees, Johnson, and Lewinson 2009). Similar to the importers, there may also 
be extra domains fused to the NBD and/or TMD of ABC exporters with additional functions 
(Biemans-Oldehinkel, Doeven, and Poolman 2006).  
 
In humans, there are 48 different ABC transporters that are classified into seven subfamilies (ABCA-
ABCG). Transporters in the ABCA subfamily are thought to be important in lipid trafficking, and 
mutations can lead to genetic diseases such as Tangier disease and age-related macular degeneration 
(Vasiliou, Vasiliou, and Nebert 2009). ABCB subfamily transporters are involved in multidrug 
resistance (Borst and Schinkel 2013) and mitochondrial iron homeostasis (Pondarre et al. 2006). 
ABCC family members are not only important in multidrug resistance (Cole 2014), but also 
important in ion conductance (Kleizen et al. 2020, Babenko and Bryan 2003). Transporters in the 
ABCD subfamily are primarily found in peroxisome, endoplasmic reticulum and lysosome with 
roles in lipid trafficking; mutations in ABCD1 can lead to the buildup of fatty acids in the brain, 
leading to X-linked adrenoleukodystrophy (Hlavac and Soucek 2015). In contrast, members in the 
ABCE and ABCF subfamilies lack the transmembrane domains, and they are thought to promote 
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interferon activity and inflammatory activities, respectively (Vasiliou, Vasiliou, and Nebert 2009). 
Lastly, the ABCG transporters are important in the sterol transport and multidrug resistance (Moitra 
et al. 2011) and mutations are associated with diabetes (ABCG1) (Schou et al. 2012) and 
sitosterolemia (ABCG5 and ABCGG8) (Yoo 2016).  
 
1.2 ABC Importers  
As recently as the early 2000s, structural determinations of membrane proteins were still considered 
to be extremely challenging. Instead of obtaining the entire structure of a transporter, efforts were 
first made to structurally characterize the soluble NBDs, along with any soluble transport-relevant 
protein, including the periplasmic binding proteins (PBPs) that provide the binding site for 
substrates. As the PBP carries a variety of substrates from small ions to large macromolecules, they 
present more substrate-specific biochemical information than the NBDs. The first structure of PBP 
determined was the structure of an arabinose binding protein at 5 Å resolution in 1976 (Phillips et 
al. 1976) and finally at 1.7 Å resolution in 1984 (Quiocho and Vyas 1984) with the crystallographic 
data first collected in 1974 (Quiocho et al. 1974). Following the groundbreaking work done in 
structurally characterizing the PBPs for amino acids (Saper and Quiocho 1983), ions (Pflugrath and 
Quiocho 1985) and sugars (Quiocho and Vyas 1984) by the Quiocho group, structures of many PBPs 
has been determined since then (Figure 2). 
 
PBPs generally consist of two lobes that can adopt open and closed conformations. To bind substrate 
in the closed conformation, the two lobes in the open conformation would have to come together; 
this substrate-induced conformational change of bringing the two lobes together is commonly 
described as the Venus-flytrap mechanism (Felder et al. 1999), which has been seen in many PBPs 
(Sack, Saper, and Quiocho 1989, Kandt, Xu, and Tieleman 2006, Gonin et al. 2007, Aktas et al. 
2011). The PBPs were initially classified into two classes in 1999 based on sequence alignments and 
overall structures (Fukami-Kobayashi, Tateno, and Nishikawa 1999). With more available structures 
in 2010, the PBPs were further classified into six different groups solely based on the alignments of 
the 3D structures (Berntsson et al. 2010). The classification information is as follows: i) Group 1 
PBPs are important in metal binding and they have an a-helix serving as the hinge between the two 
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lobes. ii) Group 2 PBPs mainly bind to carbohydrates and their N and C-termini are located in 
separate lobes. iii) Group 3 PBPs are generally bigger than other PBPs with molecular weight 
ranging from 55 to 70 kDa, and they bind to different substrates including oligopeptides, nickel ions, 
and arginine. The extra domain is thought to extend the binding cavity for oligopeptide binding. iv) 
Group 4 PBPs’ hinge regions consist of two strands with 4-5 amino acids long, and their substrate 
ranges from carbohydrates, polyamines, tetrahedral oxyanions, to ferrous or ferric iron. v) Group 5 
PBPs are part of the tripartite ATP-independent periplasmic transporter, they have distinctive b-
strand orders and a long helix spanning over both lobes. vi) Group 6 PBPs can bind small anions and 
amino acids, such as nitrate and glycine betaine (Berntsson et al. 2010). 
 
Although PBPs could bind similar substrates, such as metals, amino acids and carbohydrates, the 
overall structures of these PBPs are rather diverse. Examples of the similarities and differences in 
the structures of PBPs are presented in Figure 2. In the mononuclear metal ion binding proteins, the 
zinc-binding protein (Figure 2a) (Lee et al. 1999) has a long helix over the binding protein, but this 
long helix is not observed in the iron-binding protein (Figure 2b) (Koropatkin et al. 2007). The 
structures of the oxyanion binding proteins, including sulfate (Figure 2c) (He and Quiocho 1993), 
phosphate (Figure 2d) (Ledvina et al. 1998) and molybdate (Figure 2e) (Hu et al. 1997), are also 
structurally different from the mononuclear ion binding proteins (Figure 2ab). Similarly, structural 
differences are also evident in the various amino acid binding proteins, including the 
leucine/isoleucine/valine-binding protein (Figure 2f) (Trakhanov et al. 2005), the cysteine-binding 
protein (Figure 2g) (Muller et al. 2005), the histidine-binding protein (Figure 2h) (Yao, Trakhanov, 
and Quiocho 1994) and the methionine-binding protein (Figure 2i) (Nguyen et al. 2015). In addition 
to the ion and amino acid binding proteins, the sugar binding proteins, including the arabinose-
binding protein (Figure 2j) (Quiocho and Vyas 1984), ribose-binding protein (Figure 2k) (Bjorkman 
et al. 1994), maltose-binding protein (Figure 2l) (Quiocho, Spurlino, and Rodseth 1997), and chitin-
binding protein (Figure 2m) are also structurally distinct. Interestingly, an oligopeptide-binding 
protein (Figure 2n) (Levdikov et al. 2005) shares a similar overall structure as the chitin-binding 
protein (Figure 2m). The ectoine-binding protein is structurally distinct from all the other binding 
proteins with the long bending helix spanning over the whole binding protein (Figure 2o) (Lecher et 
al. 2009). Lastly, the vitamin B12-binding protein (Figure 2p) (Borths et al. 2002) shares similar an 
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overall structure with the zinc-binding protein (Figure 2a), and based on the recent classification 
(Berntsson et al. 2010), these two binding proteins belong to the same group.  
 
So far, there have been four types of structurally characterized ABC importers with type I shown in 
Figure 3abcd, type II shown in Figure 3ef, type III shown in Figure 3g and type IV shown in Figure 
3h. The classification information is summarized in Table 1. The first structure determined of an 
ABC importer was the Escherichia coli vitamin B12 transporter BtuC2D2 in the substrate and 
nucleotide free conformation (Locher, Lee, and Rees 2002), and it is now classified as a type II 
importer. BtuC2D2 consist of two TMDs, BtuC, and two NBDs, BtuD. BtuC consist of 10 TMHs per 
TMD, together a full transporter has 20 TMHs in total. The highly conserved NBD, BtuD is also in 
a dimeric form, where the Walker A-motif of BtuD is in close proximity to the ABC signature motif 
of the dimeric BtuD counterpart (Locher, Lee, and Rees 2002) and this positioning of the BtuD dimer 
is important in the binding of the two molecules of ATP. During substrate translocation, the vitamin 
B12-binding protein, BtuF, delivers the vitamin B12 molecule to the BtuC2D2 transport system, 
leading to BtuC2D2F complex formation (Figure 3e) (Hvorup et al. 2007). Other than BtuC2D2F, the 
Burkholderia cenocepacia hemin transporter, BhuU2V2T (Figure 3f) (Naoe et al. 2016), the 
Haemophilus influenzae metal transporter, HI1470/1471 (Pinkett et al. 2007) and the heme 
transporter, HmuU2V2 from Yersinia pestis all share the same type II importer fold (Woo et al. 2012) 
(Table 1).  
 
In comparison to type II importers, the type I importer fold consists of less TMHs in total. The first 
type I importer fold was revealed in the structure of a molybdate ABC importer ModB2C2 from 
Archaeoglobus fulgidus complexed with its periplasmic binding protein, ModA (Figure 3a) 
(Hollenstein, Frei, and Locher 2007). Besides the highly conserved NBD, the TMD (ModB) of 
ModB2C2 only consists of six TMHs and a full transporter consists of 12 TMHs in total. Later 
structures on the Sphingomonas alginate transporter system revealed a similar fold with six TMHs 
per TMD (Figure 3ab) (Maruyama et al. 2015). Interestingly, there are also heterodimeric type I 
importers. One example is the Escherichia coli maltose transport system. The two distinct TMDs 
(MalF and MalG) contain eight and five TMHs, respectively (Figure 3c) (Oldham et al. 2007). 
Lastly, the TMDs in the Escherichia coli methionine transport system consist of five TMHs per 
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TMD (Figure 3d) (Kadaba et al. 2008, Nguyen et al. 2018) and this same fold was also seen in an 
arginine/histidine transporter, ArtQ2N2 from Caldanaerobacter subterraneus (Yu et al. 2015).  
 
In contrast, type III importers present a different case where one TMD contains eight helices with 
five TMHs and three additional helices almost diagonally spanning over the membrane, and a second 
TMD containing seven helices with four TMHs as shown in the cobalt energy-coupling factor 
transporter, CbiMNQO from Rhodobacter capsulatus (Figure 3g) (Bao et al. 2017). A similar type 
III importer fold has also been reported for the folate ECF transporter from Lactobacillus brevis 
(Wang et al. 2013) and the cobalamin ECF transporter from Lactobacillus delbrueckii (Santos et al. 
2018). Besides type I, II, and III importer folds, the type IV importer fold has only been seen with 
the Escherichia coli siderophore importer, YdtPQ. Each TMD of YdtPQ consists of six TMHs 
(Figure 3h) and each TMD is fused to a NBD, forming a half-transporter and the full transporter is 
a dimer of two half-transporters (Figures 3h) (Wang, Hu, and Zheng 2020); this architecture is a 
surprisingly similar architecture to the type I ABC exporters (Figures 4 and 5, Tables 1 and 2).  
 
1.3 ABC Exporters 
Similar to the ABC importers, structural analysis of prokaryotic ABC exporters revealed a significant 
amount of structural diversity (Table 2). The type I ABC exporter fold was first revealed through the 
structure of the bacterial multidrug transporter Sav1866 from Staphylococcus aureus (Dawson and 
Locher 2006). Each TMD of Sav1866 consists of six TMHs, five of which are long helices that 
extrude out from the membrane toward the NBDs (Figure 4a) and each of the TMDs is fused with 
an NBD, forming a half-transporter which makes the whole Sav1866 transporter a homodimeric 
exporter. Subsequent structural analysis of a polypeptide transporter, PCAT1 from 
Hungateiclostridium thermocellum, also revealed a similar TMD fold, but it has additional peptidase 
domains on the N-termini of the TMDs (Figure 4b) (Lin, Huang, and Chen 2015). Similarly, the 
lipid-linked oligosaccharide flippase transporter, PglK from Campylobacter jejuni has extra helices 
on the periplasmic side of the membrane (Figure 4c) (Perez et al. 2015). Besides the homodimeric 
type I exporters, there are heterodimeric transporters consisting of two different half-transporters, 
such as the Thermus thermophilus multidrug transporter, TmrAB (Noll et al. 2017).  
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Unlike type I exporters, the prokaryotic type II exporters have six short TMHs per TMD, and the 
TMDs are separated from the NBD. Some of the type II exporters included the polysaccharide 
transporter (Figure 4d) (Bi et al. 2018), the wall teichoic acid transporter (Figure 4e) (Chen et al. 
2020), the lipopolysaccharide transporter (Figure 4fg) (Li, Orlando, and Liao 2019, Owens et al. 
2019) and the toluene tolerance efflux MLA complex (Figure 4g) (Kamischke et al. 2019). In 
addition, extra domains can form complexes with the transporters, which were revealed in the 
lipopolysaccharide transporter, LptB2FGC (Figure 4g) and the MLA complex for toluene tolerance 
efflux (Figure 4h). Lastly, the type III exporter fold was first seen in MacB, a bacterial tripartite 
transporter, consisting of two short TMHs and two long TMHs that extruded to the periplasm and 
are fused with additional periplasmic domains that could together form the multidrug efflux complex 
with MacA and TolC (Fitzpatrick et al. 2017) (Figure 4i). This type III exporter fold was also later 
seen in a similar type of efflux pump from Streptococcus pneumoniae (Yang et al. 2018). 
 
So far, human ABC transporters and their eukaryotic homologs from the ABCA, ABCB, ABCC, 
ABCD and ABCG subfamilies have been structurally characterized as either type I or II exporters 
(Figure 5, Table 3). In eukaryotes, the exporters may either be encoded in two separate polypeptide 
chains or in a single polypeptide chain. ABCA1, a phospholipid exporter, is encoded as a single 
polypeptide chain and its single-particle cryo-EM structure revealed not only the core domains, but 
also two extracellular domains with an enclosed hydrophobic tunnel and an intracellular regulatory 
domain (Figure 5a) (Qian et al. 2017). The multidrug resistance transporter, ABCB1 (also known as 
the P-glycoprotein), is encoded in one single chain containing just the core domains of two TMDs 
and two NBDs (Figure 5b) (Kim and Chen 2018). The peptide transporter, ABCB2/3 (TAP) is a 
heterodimer, encoded by two separate polypeptides (Figure 5c) (Oldham, Grigorieff, and Chen 
2016). Besides ABCB2/3, ABCB4 (Figure 5d) (Olsen et al. 2020), ABCB7 homolog (Atm1 from 
Saccharomyces cerevisiae (Srinivasan, Pierik, and Lill 2014)) (Figure 5e), ABCB8 (Figure 5f) and 
ABCB10 (Figure 5g) (Shintre et al. 2013) all share the same overall architecture as ABCB1 (Figure 
5b), which is the type I exporter fold. Members in the ABCC family, including the multidrug 
resistance protein homolog (MRP1, ABCC1) from Bos taurus (Figure 5h) (Johnson and Chen 2017), 
the cystic fibrosis transmembrane conductance regulator (CFTR, ABCC7) (Figure 5i) (Zhang, Liu, 
 8 
and Chen 2018), and ABCC8 (SUR1) in the KATP complex that functions as an ADP sensor for 
the potassium channel, Kir 6.2 (Figure 5j) (Lee, Chen, and MacKinnon 2017), all share the same 
type I exporter fold. The only structurally characterized ABCD family member, ABCD4, a 
lysosomal cobalamin exporter (Figure 5k) (Xu et al. 2019), also has long TMHs seen in other type I 
exporters in ABCB and ABCC families. In contrast to the type I exporters of the ABCB, ABCC and 
ABCD family transporters, the xenobiotics transporter, ABCG2 (Figure 5l) (Manolaridis et al. 2018), 
and the sterol transporter, ABCG5/8 (Figure 5m) (Lee et al. 2016) in ABCG family present all short 
TMs, which is a signature of a type II exporter. 
 
1.4 ABC Transporter Transport Mechanism 
The alternating access mechanism has been the most influential model to describe the transport 
mechanism of ABC transporters (Jardetzky 1966). In the basic mechanism, ABC transporters exhibit 
two major conformational states, an inward-facing conformation that opens toward the inside of a 
cell or a compartment, and an outward-facing conformation that opens toward the outside of a cell 
or a compartment. The conformational change between these two states is driven by the binding and 
hydrolysis of ATP. Structural analysis of various transporters, especially the exporters, revealed that 
in addition to the inward- and outward-facing conformations, there are also intermediate occluded 
conformational states that do not open toward either side of the membrane. In the updated alternating 
access mechanism for an ABC exporter (Figure 6a), the transported substrate binds to the inward-
facing conformation from the inside of a given compartment. Binding of ATP drives dimerization 
of the NBDs, leading to the occluded conformation with both substrate and nucleotide bound, 
followed by transition through the occluded conformation to the outward-facing conformation that 
will release the substrate to the outside compartment. ATP hydrolysis resets the transporter and the 
transport cycle starts again following the exchange of nucleotide (Figure 6a) (Rees, Johnson, and 
Lewinson 2009, Locher 2016). For an importer, substrate is delivered to the transporter by the PBP 
when the transporter occupies the outward-facing conformation (Figure 6b). Upon ATP hydrolysis, 
the transporter adopts the inward-facing conformation, accompanying by substrate release and 
dissociation of the binding protein. The transport cycle could reinitiate upon the nucleotide exchange.  
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Although this simplified alternating access model has been used to describe the substrate 
translocation mechanisms for both importers and exporters, the detailed molecular mechanism, 
including the structures of the relevant intermediates, remain less studied. Recent structural studies 
of various transporter systems and the proposed transport mechanisms emphasize that these 
transporters utilize multiple transport mechanisms. For example, the structural analysis of the 
Escherichia coli vitamin B12 transporter, BtuC2D2F, revealed an asymmetric transport mode within 
the alternating access framework, and the asymmetric state is important in preventing the leakage of 
small molecules (Korkhov, Mireku, and Locher 2012). The structural analysis of a lipid-linked 
oligosaccharide (LLO) flippase from Campylobacter jejuni supported an outward-only transport 
mechanism, in which only the outward-facing conformation of the transporter is required for the 
lipid flipping. The transporter can still alternate between the inward, and outward-facing 
conformations (Perez et al. 2015). This outward-only mechanism was subsequently invoked as the 
transport mechanism for the bacterial efflux pump, MacB (Fitzpatrick et al. 2017). On the other 
hand, a trap and flip model was proposed for the Escherichia coli lipid A transporter, MsbA (Mi et 
al. 2017) in addition to the already proposed alternating access mechanism (Ward et al. 2007). A 
crankshaft conrod mechanism was proposed for the wall teichoic acid transporter, TarG2H2 (Chen 
et al. 2020). Further, the switch model (Higgins and Linton 2004), the constant contact model 
(George and Jones 2012), and the reciprocating twin-channel model (Jones and George 2014) have 
been proposed for ABC transporters. This variety of transport mechanisms highlights that it is easier 
to propose a model than to experimentally demonstrate the validity of a model, thereby emphasizing 
the importance of detailed molecular understanding for reconstructing the transport cycle for each 
transport system. 
 
1.5 ABC Transporter Coupling Efficiencies 
In addition to the structural analysis of various ABC transporters, the functional aspects of these 
transporters are critical for understanding the transport mechanism. The central functions of an ABC 
transporters are their ATPase activities and transport activities. The ATPase activities of ABC 
transporters can be measured robustly in detergent, nanodiscs, and proteoliposomes using various 
methods for quantifying the release of inorganic phosphate. In contrast, the transport activity 
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measurements present a bigger challenge as the reaction setup requires two separate compartments 
to measure substrate translocation. As a consequence, these reactions are typically conducted with 
either proteoliposomes or membrane vesicles (Geertsma et al. 2008, Glavinas et al. 2008).  
 
ABC transporters are generally associated with basal ATPase activities, that is the turnover of ATP 
in the absence of substrates. The basal activities of these transporters can vary greatly depending on 
the membrane environments. For example, the basal activity of the Escherichia coli vitamin B12 
importer BtuC2D2 in proteoliposomes is 180 nmole/min/mg transporter, but in different detergents, 
the basal ATPase activity varies from ~300 to ~1,000 nmole/min/mg transporter (Borths et al. 2005). 
In addition, the measured basal ATPase activity for P-glycoprotein was ~100 to ~200 nmole/min/mg 
transporter in proteoliposomes with the variability resulted from the lipid composition, and ~1,450 
to ~2,450 nmole/min/mg if the transporter is only embedded in plasma membrane (Dong, Penin, and 
Baggetto 1996). The origin of these basal activities of ABC transporters are unclear, but studies on 
BtuC2D2 revealed that its basal ATPase activity is important in keeping a more functional and stable 
transporter, which would become more active during substrate translocation (Livnat-Levanon et al. 
2016). The basal ATPase activity in the Lactococcus lactis amino acid transporter GlnPQ was caused 
by the docking of unliganded PBP (Lycklama et al. 2018). These substrate-stimulated ATPase 
activities are generally within a few folds of increases of the basal activities of the transporters. In 
the case of BtuC2D2, the ATPase rate increased by about one-fold in proteoliposomes, but decreased 
by about two-fold and stimulated by about 50% depending on the detergent condition (Borths et al. 
2005). The stimulation of drugs on the basal ATPase rates of P-glycoprotein varied from one to two 
fold with dependence on the membrane lipid composition (Dong, Penin, and Baggetto 1996), and 
the stimulation could be as high as about eight times in detergent for P-glycoprotein (Aller et al. 
2009). A summary of the ATPase activities measured for different transporters in the presence of 
substrates is shown in Table 4.  
 
In order for substrate transport to happen for an ABC transporter, it requires its transport activity to 
be driven by the hydrolysis of ATP by providing the driving force for translocation. The transport 
activities of ABC transporters are usually measured in reconstituted proteoliposomes or membrane 
vesicles, in which there will be two separate compartments, namely, the inside and outside of the 
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proteoliposomes or membrane vesicle. In the case of proteoliposomes, it is commonly assumed 
that the orientation of the transport is 50% NBD-in and 50% NBD-out per reconstituted 
proteoliposome (Geertsma et al. 2008). But in the case with membrane vesicles, all transporters in 
the membrane will have the same orientation, either NBD-in or NBD-out (Glavinas et al. 2008). As 
ATP binds to the NBD of ABC transporters, it is required that ATP is placed on the same side as the 
NBD. One of the possible setups for an ABC importer is making use of the transporters with NBDs 
positioned on the inside of the proteoliposomes by supplying an ATP-regeneration system on the 
inside and the substrate on the outside of the proteoliposomes. The amount of imported substrate 
could be quantified by measuring the amount of accumulated substrate on the inside by collecting 
the proteoliposomes. In comparison, the exporter function is easier to test. One can make use of the 
transporters with NBDs positioned on the outside of the proteoliposomes and supply both substrate 
and ATP on the outside. The exported substrate will accumulate on the inside of the proteoliposomes 
and the amount of substrate could be quantified (Geertsma et al. 2008).  
 
Although the transport assay is rather easy to set up, there are different factors that could affect the 
final transport activity. One factor is the reconstitution efficiency. During reconstitution of 
transporters into liposomes, not all transporters will get incorporated. This will result in a lower 
reconstitution efficiency as seen in the BtuC2D2 reconstitution (Borths et al. 2005). But this could be 
easily corrected by analyzing the amount of protein in the total reconstitution and in the 
proteoliposomes-only samples using SDS-PAGE. One other factor related to the reconstitution is the 
orientation effects. Transporters may preferentially be inserted into the membrane in one way or 
another, and thus the assumption of 50% in and 50% out would be incorrect. Further, the 
reconstituted proteoliposomes are highly unstable, the unilamella proteoliposomes may not only fuse 
with each other forming large unilamella vesicles, but they may also form multilamellar vesicles 
which will result in underestimation of the actual transport activities. Some of the transport activities 
of ABC transporters are summarized in Table 4. The transport activities of different transporters 
range from 0.03 to 1,200 nmole/min/mg transporter. With an estimate molecular weight of 120 kDa 
(1 mg protein @ 8 nmole protein) for most of these ABC transporters, the transport rates are estimated 
to be 0.004 min-1 to 150 min-1 or 0.0001 s-1 to 2.5 s-1. This is significantly slower than the P-type 
ATPases that have a transport rate of about 102 s-1 (Skou 1998). In addition, secondary transporters 
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can exhibit much higher rates, such as the band 3 anion exchanger with a transport rate on the 
order of 104 s-1 (Brahm 1977, Hsu 2018), the chloride channels has a rate close to 103 s-1 (Jayaram et 
al. 2008), the glucose transporter has a transport rate on the order of 103 s-1 (Mueckler and Thorens 
2013), and the lactose transporter has a transport rate of ~20 s-1 (Viitanen, Garcia, and Kaback 1984). 
These different membrane transport systems are significantly faster than ABC transporters, which 
raise the questions of why ABC transporters are so slow and what are some factors that could limit 
their rate of transport. 
 
The ATPase and transport activities of a given transporter may be used to calculate the coupling 
efficiency, which is given by the ATPase rate divided by the transport rate, to yield the number of 
ATP molecules hydrolyzed for one substrate molecule translocated. As ABC transporters present 
two NBDs, it is commonly thought that two ATP molecules are required per substrate translocation, 
but coupling efficiency of 2 has only been realized for the amino acid importer, GlnPQ (Lycklama 
et al. 2018), P-glycoprotein (Eytan, Regev, and Assaraf 1996), and the sterol transporter ABCG5/8 
(Wang et al. 2006) (Table 4). In other transporter systems, significant variations in the coupling 
efficiency have been reported. For example, the coupling efficiency for the maltose transporter 
MalFGK2 in different studies ranges from 1.4 to over 3000 ATP/transported substrate (Table 4), 
which must arise from differences in the experimental protocols for reconstitution and transport 
characterization. The uncoupled activity could reflect the operation of two parallel, functionally 
relevant pathways for ATP hydrolysis that differ by the presence or absence of the transported 
substrate as proposed for certain ABC importers (Lewinson and Livnat-Levanon 2017) and ABC 
exporters (Hofmann et al. 2019). The inefficient coupling of ABC transporters is also reminiscent of 
the properties of binding protein independent variants of the maltose transporter that exhibit 
constitutive ATPase activity (Covitz et al. 1994); this suggests that the uncoupled ATPase activity 
may also be associated with the ability to transport more weakly bound substrates in the absence of 
a binding protein. Understanding the origins of this uncoupling will be critical for the detailed 
dissection of the transport mechanism to assure that the ATP-dependent steps are indeed relevant to 
substrate translocation. 
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1.6 Mitochondrial ABC Transporters 
The ABC transporter of mitochondria (Atm1) was first identified in Saccharomyces cerevisiae with 
localization to the inner membrane of mitochondria as a homodimer (Lill and Kispal 2001). Atm1-
deficient mitochondria accumulate ~30x more non-heme iron (II) (Miao et al. 2009) than wild type 
mitochondria (Kispal et al. 1997), suggestive of an important role in mitochondrial iron homeostasis. 
In addition, while depletion of Atm1 from mitochondria has no effect on assembly of mitochondrial 
iron-sulfur cluster proteins, the biosynthesis of cytosolic iron-sulfur cluster proteins is significantly 
impaired. This observation suggests that Atm1 participates in the maturation of cytosolic iron-sulfur 
cluster proteins through the transport of one or more essential components or perhaps a regulatory 
species (Miao et al. 2009). Later studies demonstrated that thiol compounds, including cysteine, 
glutathione, oxidized glutathione (Kuhnke et al. 2006), and the glutathione persulfide (Riedel et al. 
2019) could stimulate the ATPase activities of Atm1 and are thus potential substrates for Atm1. 
Additional studies on the Arabidopsis homolog atm3 revealed that it is not only important in iron-
sulfur cluster biogenesis (Bernard et al. 2009, Zuo et al. 2017), but also in molybdenum cofactor 
biosynthesis (Teschner et al. 2010). 
 
Humans contain four mitochondrial ABC transporters: ABCB6, ABCB7, ABCB8 and ABCB10. 
Among the four, ABCB7 and ABCB6 share 50% and 40% sequence identities with yeast Atm1, 
respectively. Studies on ABCB7 and its orthologs have shown that this transporter has an essential 
role in iron-sulfur cluster biogenesis (Pondarre et al. 2006) and heavy metal detoxification 
(Lerebours, To, and Bourdineaud 2016). Mutations in ABCB7 are associated with X-linked 
sideroblastic anemia in humans (Bekri et al. 2000). ABCB6 was first found to be a porphyrin 
transporter (Krishnamurthy et al. 2006) in the outer membrane of mitochondria, and was 
subsequently shown to protect cells against arsenic toxicity (Chavan, Oruganti, and Krishnamurthy 
2011) and to have a role in cadmium detoxification (Rakvacs et al. 2019). In addition to 
mitochondria, ABCB6 has also been demonstrated to localize to the plasma membrane (Paterson et 
al. 2007), the Golgi apparatus (Tsuchida et al. 2008), and lysosome (Kiss et al. 2012).  
 
In an effort to structurally characterize Atm1 and its homologs to understand the underlying transport 
mechanism, previous efforts from our lab set the groundwork by characterizing a bacterial homolog 
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of Atm1/ABCB7/ABCB6. Through a funnel approach optimizing cloning, expression, 
purification, and crystallization, an Atm1 homolog from Novosphingobium aromaticavorans 
(NaAtm1) was selected which shares sequence identities of ~45% with the yeast Atm1 and the 
human ABCB7 and ABCB6. The structure of NaAtm1 was determined in the inward-facing 
conformation, in apo, glutathione (GSH), oxidized glutathione (GSSG), and glutathione-mercury 
complex (GS-Hg) bound states (Lee et al. 2014). The structural studies established that NaAtm1 
folds as a homodimer with two identical half-transporters and is a member of the type I exporter 
family containing six TMHs in the TMDs (Figure 7ab). In vitro assays revealed that the ATPase 
activities of NaAtm1 could be greatly stimulated by glutathione-silver and glutathione-mercury 
complexes, while in vivo assays demonstrated that overexpression of NaAtm1 in heavy metal 
sensitive Escherichia coli strains conferred protection against toxic concentrations of Ag+ and Hg2+. 
These observations are suggestive of a heavy-metal detoxification function for NaAtm1, plausibly 
by exporting heavy metal derived GSH complexes (Lee et al. 2014). Two GSSG binding sites were 
identified in the structure (Figure 7a), a primary binding site deep into the lipid bilayer and a 
secondary binding site with a relatively lower occupancy closer to the cytoplasm. In both sites, GSSG 
forms extensive interactions with residues in the binding pocket (Figure 7cd). The relative positions 
of the two GSSG molecules are suggestive of a potential binding mode of a [2Fe:2S][GS-]4 complex 
that has been proposed as a potential substrate for Atm1 (Qi et al. 2012).  
 
1.7 Purpose of Study 
There has been a recent explosion in the structure determinations of ABC transporters, reflecting the 
resolution revolution in the field of single-particle cryo-electron microscopy. Despite these structural 
advances, functional characterizations of ABC transporters have been more challenging. This is 
largely because characterizing the functional aspects of ABC transporters necessitates measurement 
of the transport activity. As discussed above, transport measurements are challenging due to the 
requirement to faithfully reconstitute transporters into proteoliposomes and because of the high basal 
ATPase rate. As a consequence, fundamental questions concerning the transport mechanism remain 
unclear. The mechanistic questions are compounded by the variety of transport mechanisms that 
have been proposed for ABC transporters, including the alternating access model (Ward et al. 2007, 
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Khare et al. 2009, Nguyen et al. 2018), the outward only model (Perez et al. 2015, Fitzpatrick et 
al. 2017), and the trap and flip model (Mi et al. 2017). The diversity of mechanistic proposals 
reinforces the concept that despite having a common nucleotide driven engine, details of the transport 
mechanism may differ significantly among the ABC transporter family. Even such basic questions 
as the location(s) of the substrate binding site(s) and the origins of the transport directionality of 
importers and exporters, are not well understood.  
 
In consideration of the current state of the ABC transporter field, NaAtm1 presents a great 
opportunity since substrates have been defined, and the structure has been characterized to high 
resolution with X-ray crystallography. Consequently, I set out to use NaAtm1 as a model system to 
understand the transport mechanism for human ABC transporter homologs with two objectives: 
1) elucidate the transport mechanism of NaAtm1 by structurally characterizing other 
conformational states in the transport cycle in the presence and absence of substrates and various 
nucleotides, using X-ray crystallography and single-particle cryo-electron microscopy, and  
2) functionally characterize NaAtm1 through both ATPase and transport assays.  
 
In addition to my studies on the NaAtm1 exporter system, many PBPs from the ABC importer 
systems have been recently redesigned as biosensors for cellular usages because of their substrate 
diversity. The Lester group has been actively working on developing and characterizing biosensors 
for smoking cessation drugs and neurotransmitters in collaboration with the Looger group at HHMI. 
Structures of the liganded states of the biosensors are crucial in the directed evolution of these 
biosensors. I thus set out to determine structures of these biosensors to guide its design for better 
binding specificity. 
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1.8 Figures 
 
 
Figure 1. Overview of ABC transporter.  
(a) ABC transporter overall architecture illustrating the directions of import and export. (b) 
Structural features of a nucleotide-binding domain present in ABC transporters. The conserved 
sequences motifs are labeled.  
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Figure 2. Crystal structures of periplasmic binding proteins.  
Structures of (a) the zinc-binding protein from Treponema pallidum, (b) the iron-binding protein 
from Synechocystis, (c) the sulfate-binding protein from Salmonella typhimurium, (d) the phosphate-
binding protein from Escherichia coli, (e) the molybdate-binding protein from Escherichia coli, (f) 
the leucine/isoleucine/valine-binding protein from Escherichia coli, (g) the cysteine-binding protein 
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from Campylobacter jejuni, (h) the histidine-binding protein from Escherichia coli, (i) the 
methionine-binding protein from Escherichia coli, (j) the arabinose-binding protein from 
Escherichia coli, (k) the ribose-binding protein from Escherichia coli, (l) the maltose-binding 
protein from Escherichia coli, (m) the chitin-binding protein from Vibrio cholerae, (n) the peptide-
binding protein from Bacillus subtilis, (o) the ectoine-binding protein from Ruegeria pomeroyi, and 
(p) vitamin B12-binding protein from Escherichia coli. The corresponding PDB IDs are labeled 
below each structure.  
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Figure 3. Structures of the prokaryotic ABC importers.  
(a) Crystal structure of the Archaeoglobus fulgidus molybdate importer complex, ModB2C2A. (b) 
Crystal structure of the Sphingomonas sp. alginate importer complex, AlgM1M2S2Q. (c) Crystal 
structure of the Escherichia coli maltose importer complex, MalFGK2E. (d) Crystal structure of the 
Escherichia coli methionine importer complex, MetN2I2Q. (e) Crystal structure of the Escherichia 
coli vitamin B12 importer complex, BtuC2D2F. (f) Crystal structure of the Burkholderia cenocepacia 
hemin importer complex, BhuU2V2T. (g) Crystal structure of the Rhodobacter capsulatus energy-
coupling-factor (ECF), CbiMNQO. (h) Single-particle cryo-EM structure of the Escherichia coli 
siderophore importer, YbtPQ. The corresponding PDB IDs are labeled below each structure.  
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Figure 4. Structures of the prokaryotic ABC exporters.  
(a) Crystal structure of the Staphylococcus aureus multidrug transporter, Sav1866. (b) Crystal 
structure of the Hungateiclostridium thermocellum PCAT1. (c) Crystal structure of the 
Campylobacter jejuni lipid-linked oligosaccharide transporter, PglK. (d) Crystal structure of the 
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Aquifex aeolicus O-antigen polysaccharide exporter, Wzm-Wzt. (e) Single-particle cryo-EM 
structure of the Alicyclobacillus herbarius wall teichoic acid exporter, TarG2H2. (f) Single-particle 
cryo-EM structure of the Escherichia coli lipopolysaccharide exporter, LptB2FG. (g) Single-particle 
cryo-EM structure of the Enterobacter cloacae lipopolysaccharide exporter, LptB2FGC. (h) Single-
particle cryo-EM structure of the Acinetobacter baumannii MLA complex. (i) Single-particle cryo-
EM structure of the Escherichia coli tripartite efflux pump, MacB in complex with MacA and TolC. 
The corresponding PDB IDs are labeled below each structure.  
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Figure 5. Structures of the eukaryotic ABC exporters.  
(a) Single-particle cryo-EM structure of the human phospholipid and cholesterol transporter, 
ABCA1. (b) Single-particle cryo-EM structure of the human multidrug transporter, ABCB1 (Pgp, 
P-glycoprotein). (c) Single-particle cryo-EM structure of the human peptide transporter, ABCB2/3 
(TAP-transporter associated with antigen processing). (d) Single-particle cryo-EM structure of the 
human phosphatidylcholine transporter, ABCB4. (e) Crystal structure of the human glutathione and 
derivatives transporter ABCB7 homolog (Atm1- ABC transporter of mitochondria) from 
Saccharomyces cerevisiae. (f) Single-particle cryo-EM structure of the human ABCB8. (g) Single-
particle cryo-EM structure of the human ABCB10. (h) Single-particle cryo-EM structure of the 
human multidrug transporter, ABCC1 (MRP1-multidrug resistance protein) homolog from Bos 
Taurus. (i) Single-particle cryo-EM structure of the human chloride channel, ABCC7 (CFTR). (j) 
Single-particle cryo-EM structure of KATP channel, a SUR1 (ABCC8) and Kir6.2 complex. (k) 
Single-particle cryo-EM structure of the human cobalamin transporter, ABCD4. (l) Single-particle 
cryo-EM structure of the human xenobiotic transporter, ABCG2. (m) Crystal structure of the human 
sterol transporter, ABCG5/8. The corresponding PDB IDs are labeled below each structure. 
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Figure 6. The alternating access transport model. 
The alternating access mechanism for (a) an ABC exporter, and (b) an ABC importer. 
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Figure 7. Crystal structure of NaAtm1 in the inward-facing conformation.  
(a) Overall cartoon representation of NaAtm1 with two GSSG bound. One half-transporter is shown 
in green and the second half-transporter is shown in cyan. (b) NaAtm1 half-transporter with the 
TMD and NBD labeled. (c) GSSG in the primary binding site with interactions to the nearby 
residues. (d) GSSG in the secondary binding site with interactions to the nearby residues. Residues 
from the two chains are labeled in green and cyan, respectively. PDB ID: 4MRS. 
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1.9 Tables 
 
Table 1. Summary of ABC importer structures.  
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Table 2. Summary of prokaryotic ABC exporter structures.  
 
  
 28 
Table 3. Summary of eukaryotic ABC exporter structures.  
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Table 4. Summary of coupling efficiencies.* 
 
 
*References: Zehnpfennig, Urbatsch, and Galla 2009, Davidson and Nikaido 1990, Patzlaff, van der 
Heide, and Poolman 2003, Lycklama et al. 2018, Eytan, Regev, and Assaraf 1996, Wang et al. 2006, 
Dean, Davidson, and Nikaido 1989, Dong, Penin, and Baggetto 1996, Nikaido and Ames 1999, 
Manolaridis et al. 2018, Hofmann et al. 2019, Borths et al. 2005, Woo et al. 2012, Chen et al. 2001, 
Chavan et al. 2013. 
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C h a p t e r  2  
A STRUCTURAL FRAMEWORK FOR THE UNIDIRECTIONAL 
TRANSPORT OF A BACTERIAL ABC EXPORTER 
This chapter is adapted from:  
Fan, C., Kaiser, J.T. and Rees, D.C. “A structural framework for the unidirectional transport by 
a bacterial ABC exporter.” In revision. 
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2.1 Abstract 
The ATP-binding cassette (ABC) transporter of mitochondria (Atm1) mediates iron homeostasis in 
eukaryotes, while the prokaryotic homolog from Novosphingobium aromaticivorans (NaAtm1) can 
export glutathione derivatives and confer protection against heavy metal toxicity. To establish the 
structural framework underlying the NaAtm1 transport mechanism, we determined eight structures 
by X-ray crystallography and single particle cryo-EM in distinct conformational states, stabilized by 
individual disulfide crosslinks and nucleotides. As NaAtm1 progresses through the transport cycle, 
conformational changes in transmembrane helix 6 (TM6) alter the glutathione binding site and the 
associated substrate binding cavity. Significantly, kinking of TM6 in the post-ATP hydrolysis state 
stabilized by MgADPVO4 eliminates this cavity, precluding uptake of glutathione derivatives. The 
presence of this cavity during the transition from the inward-facing to outward-facing 
conformational states, and its absence in the reverse direction, thereby provides an elegant and 
conceptually simple mechanism for enforcing the export directionality of transport by NaAtm1. One 
of the disulfide crosslinked NaAtm1 variants characterized in this work retains significant 
glutathione transport activity, suggesting ATP hydrolysis and substrate transport by Atm1 may 
involve a limited set of conformational states with minimal separation of the nucleotide binding 
domains in the inward-facing conformation.  
 
2.2 Significance Statement 
ATP Binding Cassette (ABC) transporters are generally viewed to function as either exporters or 
importers, but in principle they could transport substrates in either direction across the membrane. 
Structural studies of the prokaryotic ABC exporter NaAtm1 demonstrate that progression through 
the transport cycle is accompanied by changes in transmembrane helix 6 (TM6) that modulate the 
binding cavity for transported substrate. Significantly, kinking of TM6 in a post-ATP hydrolysis 
state stabilized by MgADPVO4 eliminates the substrate binding cavity. The presence of this cavity 
during the transition from the inward-facing to outward-facing conformational states, and its absence 
in the reverse direction, thereby provides an elegant and conceptually simple mechanism for 
enforcing the export directionality of transport. 
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2.3 Introduction 
The translocation mechanism of ATP Binding Cassette (ABC) transporters is generally described in 
terms of the alternating access model involving inward-facing, occluded and outward-facing states, 
with the transitions between states coupled to the binding and hydrolysis of ATP, along with product 
release (Higgins 1992, Davidson et al. 2008, Rees, Johnson, and Lewinson 2009, Locher 2016, 
Thomas and Tampe 2018). ABC exporters constitute an important branch of ABC transporters found 
in all forms of life, exhibiting a broad range of activities from exporting macromolecular building 
blocks to serving as multidrug efflux pumps. Despite the name, it has generally not been 
experimentally demonstrated that exporters have a unique transport directionality, or how this 
directionality is maintained. An informative example is provided by the recent studies of 
mycobacterial ABC transporters with an exporter fold that mediates the uptake of cobalamin and 
other hydrophilic compounds (Rempel et al. 2020, Arnold et al. 2020). The structural 
characterization of ABC exporters in distinct conformational states has been primarily achieved by 
controlling the nucleotide state, often in combination with the ATPase deficient “E to Q” mutant in 
the Walker-B motif (Moody et al. 2002). Other approaches to stabilizing specific conformational 
states include introduction of disulfide crosslinks between the nucleotide binding domains (NBDs) 
(Korkhov, Mireku, and Locher 2012, Alam et al. 2018), or through the binding of state-specific 
nanobodies (Alam et al. 2019), inhibitors (Alam et al. 2018), or substrate (Johnson and Chen 2017). 
Detailed structural frameworks are now available for addressing the transport mechanism of different 
ABC exporter systems, including CFTR (Liu et al. 2017, Zhang, Liu, and Chen 2017, Liu et al. 
2019), MsbA (Ward et al. 2007, Mi et al. 2017), TmrAB (Hofmann et al. 2019), PglK (Perez et al. 
2019), and P-glycoprotein (Aller et al. 2009, Jin et al. 2012, Kim and Chen 2018, Alam et al. 2018) 
in distinct conformational states. These studies reinforce the view that significant conformational 
variability exists between different members of the ABC exporter family.  
 
The ABC-transporter of mitochondria (Atm1) is a homodimeric transporter that was first shown to 
be involved in iron-sulfur cluster biogenesis in yeast (Kispal et al. 1997); it is also a homolog to the 
human ABCB6 and ABCB7 transporters and plant atm3 transporter that were all found to play a role 
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in iron homeostasis (Lill and Kispal 2001, Pondarre et al. 2006, Cavadini et al. 2007, Zuo et al. 
2017). Previous analysis of the bacterial homolog from Novosphingobium aromaticivorans 
(NaAtm1) revealed a role in heavy metal detoxification, plausibly by exporting metallated 
glutathione species (Lee et al. 2014). The initial characterization of NaAtm1 established the structure 
in an inward-facing conformation and defined the binding interactions for glutathione derivatives 
(Lee et al. 2014). To stabilize NaAtm1 in different conformations states, we introduced disulfide 
crosslinks at multiple positions within the NBD dimerization interface. In this work, we report the 
structures and functions of disulfide crosslinking variants, together with the “E to Q” ATP-hydrolysis 
deficient mutant and wild type NaAtm1, in distinct conformational states. From these structures, a 
framework for the transport cycle of NaAtm1 is delineated. Unexpectedly, one of the crosslinked 
variants retained significant GSSG transport activity and further exhibited improved coupling 
efficiency between ATP hydrolysis and GSSG transport relative to wild type protein, highlighting 
the role of conformational dynamics in the coupling mechanism. A prominent feature of the transport 
cycle is the coupling between the conformation of transmembrane helix 6 (TM6) and the glutathione 
binding site. During the transition from inward to outward conformation, a large binding cavity 
exists, but in the return process, as trapped by MgADPVO4 in a post-ATP hydrolysis state, kinking 
of TM6 eliminates this cavity. The net effect would be to restrict glutathione transport to the export 
direction, providing a mechanism for enforcing directionality of the transport mechanism. 
 
2.4 Results 
Disulfide crosslinking 
To stabilize NaAtm1 in distinct conformational states, we introduced cysteine mutations at the 
dimerization interface between the NBDs of the natively cysteine-less homodimeric NaAtm1. Three 
residues identified through sequence alignments of NaAtm1 to other transporters with dimerized 
NBDs (Dawson and Locher 2006, Korkhov, Mireku, and Locher 2012, Alam et al. 2018) are T525, 
S526, and A527, positioned near the Walker-B motif where disulfide bonds could potentially form 
between the two equivalent residues (Figure S1a). These residues were separately mutated to 
cysteine to generate three single-site variants: NaT525C, NaS526C, and NaA527C. Initial 
crosslinking tests with purified protein revealed that similar crosslinking yields at ~70% (Figure 
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S1b). We crystallized and solved the structures of all three variants to assess the consequences of 
the disulfide crosslinks on the conformational states of NaAtm1.   
 
Crystal structures of inward-facing occluded conformations 
NaA527C crystallized in a MgADP bound state with four transporters in the asymmetric unit. 
Despite the moderate anisotropic diffraction to 3.7 Å resolution, two distinguishable inward-facing 
occluded states, designated state #1 (Figure 1a) and state #2 (Figure 1b), were evident. The presence 
of two conformational states was confirmed from the positions of the selenium sites in 
selenomethionine substituted protein crystals (Figure S2a). Clear electron density was observed for 
the disulfide bridges and the nucleotides in all four transporters (Figure S2bc). A structural alignment 
of the two states revealed that while the transmembrane domains (TMDs) are structurally similar, 
sharing an overall RMSD of 1.7 Å (Figure S3a), the a-helical subdomains of the NBDs differ by a 
small rotation (~10°) about the molecular two-fold axis of the transporter (Figure S3b). These two 
states also differ from the previous NaAtm1 inward-facing conformation with RMSDs of 2.1 Å and 
4.4 Å for state #1 and state #2, respectively (Figure S3cd); the primary differences are in the 
separation of the NBDs and changes near the coupling helices of the TMDs that interact with the 
NBDs.   
 
Crystals of NaA527C were prepared either with or without 5 mM GSSG. While weak density in the 
substrate binding pocket was observed for crystals grown in the presence of GSSG, the moderate 
resolution was insufficient to unambiguously establish the presence of GSSG. To 
crystallographically assess the substrate binding capability of NaA527C, we co-crystallized 
NaA527C with a glutathione-mercury complex (GS-Hg) and collected data at the Hg absorption 
edge. Anomalous electron density peaks identifying Hg sites were found in all GSSG binding sites 
(Lee et al. 2014) and were strongest in the two best resolved transporters in the asymmetric unit 
(Figure S4). These sites were not observed in control studies using mercury compounds in the 
absence of glutathione, supporting the presence of GS-Hg and the substrate binding capability of 
NaA527C. 
 
Crystal structures of the pre-hydrolysis occluded conformations  
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Crystals of NaS526C diffracted anisotropically to 3.4 Å resolution, and the transporter adopted an 
occluded conformation with bound ATP and a fully resolved disulfide bridge (Figure 1c, S5ab). 
Even though GSSG or GS-Hg were included during crystallization, the binding of substrate was not 
detected in the electron density maps. The periplasmic regions of the transporter (residues 60-82 and 
284-300) were not well resolved in the electron density maps, possibly due to the lack of stabilizing 
crystal contacts. These regions were accordingly modeled based on the previously determined high-
resolution crystal structure and refined with reduced occupancies. 
 
Surprisingly, crystals of NaT525C were nearly isomorphous to those of NaS526C, and the structures 
were found to be quite similar (Figure 1d). In contrast to the NaA527C and NaS526C structures, 
however, no disulfide bridge was observed between the two T525C residues (Figure 1d, S5cd). 
Instead, the two T525C residues were 13 Å apart, calculated from the corresponding Ca positions. 
Since no reductant was present, presumably crystallization of the crosslinked protein was not favored 
in this condition and instead the uncrosslinked population crystallized.  
 
Crystals of the ATP-hydrolysis deficient NaE523Q diffracted anisotropically to 3.3 Å resolution and 
the structure revealed the occluded conformation with ATP bound (Figure 1e, S5e). While the overall 
structure of NaE523Q was similar to that observed for NaS526C and NaT525C, including the 
flexible periplasmic loops, the crystal form was distinct. Overall, the three occluded structures are 
similar with RMSDs in the range of 0.5 - 0.7 Å (Figure S5fgh). 
 
Wild type NaAtm1 was crystallized in an occluded state with bound MgAMPPNP (Figure 1f, S6a). 
This occluded structure shared a similar overall architecture with the other three mutant occluded 
structures with alignment RMSDs of ~1 Å (Figure S6bcd); the major conformational differences are 
in the resolved periplasmic loop regions and the partially resolved elbow helices. Although GSSG 
was present in the crystallization conditions, bound substrate was not evident in the crystal structure, 
which is the same outcome observed for the other occluded structures.   
 
Single-particle cryo-EM structure of the post-hydrolysis closed conformation  
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To capture the post-hydrolysis state of the transporter, we utilized the post-hydrolysis ATP analog 
MgADPVO4 (Goodno 1982) and determined a single-particle cryo-EM structure of NaAtm1 in a 
closed conformation at 3.0 Å resolution (Figure 1g, S7abc). For this analysis, NaAtm1 was 
reconstituted in nanodiscs formed by the membrane scaffolding protein MSP1D1 (Ritchie et al. 
2009). The overall architecture of this single particle structure has RMSDs in the range of 1.7 - 2.1 
Å with the crystal structures in the pre-hydrolysis occluded state (Figure S7defg). These structures 
all adopt similarly dimerized NBDs, but with pronounced differences in the TMDs. The kinked TM6 
observed in the post-hydrolysis MgADPVO4 occluded structure contrasts with the straightened 
conformation observed in the pre-hydrolysis occluded states; as a consequence of this structural 
change, the GSSG binding cavity is eliminated and so this form is designated as a “closed” state.  
 
Single-particle structure of the inward-facing conformation 
We determined an inward-facing conformation of NaAtm1 reconstituted into nanodiscs by single 
particle cryo-EM in the absence of ligands. This reconstruction was obtained at 3.9 Å resolution 
(Figure 1h, S8ab) where large side chains are well resolved (Figure S8c). This structure is designated 
as a “wide-open” inward-facing conformation, since the NBDs are significantly further apart in 
comparison to the original crystal structures of NaAtm1. The RMSDs between this structure and 
other inward-facing conformation (Lee et al. 2014) and the inward-facing occluded structures are in 
5.8 - 9.3 Å, with the major difference in the separation of the two half-transporters (Figure S8def). 
 
ATPase activities, transport activities and coupling efficiencies of all variants 
To establish the functional competence of the disulfide crosslinked variants and wild type NaAtm1, 
their ATPase and transport activities were characterized (Figure 2). ATPase activities were measured 
in both detergent and proteoliposomes (PLS) with 10 mM ATP and 2.5 mM GSSG, concentrations 
approximating those measured physiologically (Bennett et al. 2009) (Figure 2ab). Wild type 
NaAtm1 in detergent showed a basal ATPase activity of 115 ± 15 nmol Pi min-1 mg-1 transporter, 
and the addition of 2.5 mM GSSG stimulated the ATPase activity by nearly 2-fold to 206 ± 8 nmol 
Pi min-1 mg-1 transporter. NaAtm1 reconstituted in PLS showed an ATPase activity of 66 ± 13 nmol 
Pi min-1 mg-1 transporter, again with ~2-fold stimulation in the presence of 2.5 mM GSSG to 152 ± 
31 nmol Pi min-1 mg-1 transporter. Based on the NaAtm1 molecular weight of 133 kDa (with 1 mg 
 
 
52 
≈ 7.5 nmole), neglecting orientation effects and assuming all the transporters are functionally 
active, an ATPase rate of 152 nmol Pi min-1 mg-1 corresponds to a turnover rate of ~20 ATP min-1. 
Unexpectedly, NaS526C had a similar basal ATPase activity to the wild type protein, with no 
stimulation by GSSG in detergent, but a slight stimulation by GSSG in PLS. NaT525C exhibited 
reduced ATPase activities in detergent and PLS. The NaA527C and NaE523Q constructs exhibited 
little ATPase activity in either detergent or PLS. 
  
The transport activity was by necessity measured only in PLS, again using 10 mM MgATP and 2.5 
mM GSSG (Figure 2cd). Control experiments indicated that low levels of GSSG may stick to 
liposomes, complicating the measurement of very low levels of transport activities. For wild type 
NaAtm1, the uptake of GSSG was linear with time, corresponding to a rate of 1.52 ± 0.03 nmol 
GSSG min-1 mg-1 transporter, equivalent to ~0.2 GSSG translocated per minute per transporter 
(Figure 2c). Interestingly, NaS526C exhibited ~ 60% of wild type transport activity at a rate of 0.9  
± 0.1 nmol GSSG min-1 mg-1 transporter (Figure 2d), while NaT525C retained about 30% of the 
transport activity of wild type NaAtm1. NaA527C and NaE523Q exhibited GSSG uptake rates ~10% 
of the wild type protein transport activity (Figure 2d). A complicating feature in the interpretation of 
these results is that since disulfide bond formation in these variants was not quantitative, we cannot 
eliminate some contribution by the uncrosslinked material to the observed ATPase and transport 
activities. If the uncrosslinked material exhibits the same activity as wild type protein, then in the 
absence of transport activity by the crosslinked protein, a residual ~30% transport activity would be 
anticipated based on the estimate of 70% disulfide bond formation. As the transport activity 
measured for the NaS526C variant exceeds this threshold, NaAtm1 with a disulfide crosslink 
between the two Cys 526 residues is competent for GSSG transport. In contrast, the transport activity 
NaT525C variant is at the 30% threshold value, and hence the transport competence of the 
crosslinked variant cannot be confidently established. 
 
From the ATPase and transport activities, the coupling efficiency - the number of ATP hydrolyzed 
per GSSG translocated - can be computed. For this calculation, we defined the coupling efficiency 
as the ratio of the total ATPase rate to the transport rate measured under the same conditions (in the 
presence of 2.5 mM substrate). For the wild type protein, the coupling efficiency is measured to be 
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100 ± 20, compared to 76 ± 6 for the NaS526C variant. Although these coupling efficiencies may 
seem high relative to the canonical value of 2 typically envisioned for ABC transporters (Patzlaff, 
van der Heide, and Poolman 2003), they are in the range reported for other transporters (Table S1), 
reflecting the generally high basal ATPase activity and coupling inefficiencies of ABC transporters.    
 
Volumes of substrate binding cavities 
The volumes of the substrate binding cavities in different structures were calculated using the 
program CastP with a 2.5 Å probe radius (Tian et al. 2018). For reference, the volume of a GSSG 
molecule (molecular weight 612.6 g mol-1) is estimated to be ~740 Å3, assuming a partial specific 
volume for GSSG typical of globular proteins (~0.73 cm3 g-1) (Erickson 2009). With the exception 
of the MgADPVO4 stabilized state, the binding pockets in the various NaAtm1 structures are all 
found to be of sufficient size to accommodate GSSG (Figure 3). Significantly, the binding pocket is 
no longer present in the “post-hydrolysis” MgADPVO4 stabilized state (Figure 3i). For reference, 
the outward-facing conformation of Sav1866 (Dawson and Locher 2006) has a cavity volume of  
~3,400 Å3 (Figure 3j). As GSSG was not experimentally found to be present in the pre-hydrolysis 
occluded conformations, the absence of substrate in these structures suggests that they may represent 
lower affinity, post-translocational states of the transporter when the empty transporter is 
transitioning back to the inward-facing conformation. The comparison with the post-hydrolysis 
occluded structure suggests that a key conformational change after ATP hydrolysis is the generation 
of kinked TM6 helices, which eliminates the central cavity. 
 
2.5 Discussion 
We have expanded the structurally characterized conformations of the ABC exporter NaAtm1 from 
the previously determined inward-facing conformation (Lee et al. 2014) to multiple occluded 
conformations, through introduction of disulfide bridges and the use of nucleotide analogs. From all 
available NaAtm1 structures, we have observed the inward-facing conformations (including the 
inward-facing occluded conformation) in either nucleotide-free or MgADP-bound forms, while the 
occluded conformations are stabilized by ATP or analogs (Figure 1). Substrates have only been 
observed to bind to the inward-facing conformations, even though substrate binding cavities of 
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sufficient size to accommodate GSSG are present in the occluded conformations (Figure 4). The 
most striking changes between these different conformational states occur in the TMDs, most 
notably in the positioning of TM4-5 described previously (Lee et al. 2014), and the straightening and 
kinking of TM6s.  
 
The conformation of TM6 is directly coupled to the binding of glutathione by NaAtm1 and hence to 
the directionality of transport. The kinking of TM6 observed in the inward-facing, inward-facing 
occluded and the post-hydrolysis occluded structures (Figure 4a), contrasts with the more subtly bent 
TM6 helices in the pre-hydrolysis occluded structures of NaAtm1 (Figure 4a). The TM6 kink present 
in the inward-facing conformation occurs adjacent to a turn of 310-helix at residues 314-317, such 
that the amide NH groups of residues 319 and 320 hydrogen bond to the a-carboxyl of the g-Glu of 
GSSG, while the a-amino group of GSSG hydrogen bonds to the carbonyl oxygen of residue 316 
(Lee et al. 2014) (Figure 4b). Upon transition to the occluded conformation of NaAtm1, TM6 adopts 
a regular a-helical structure (Figure 4c), accompanied by an increased separation between the 
symmetry related TM6s, so that these peptide bond groups are no longer available to hydrogen bond 
the transported substrate. As a consequence, as NaAtm1 transitions from the inward to outward-
facing conformational states, the binding site for the transported substrate is restructured for substrate 
release, providing a mechanism for coupling protein conformation to the ligand binding affinity. As 
NaAtm1 resets to the inward-facing conformation, kinking of TM6 in the MgADPVO4 stabilized 
form effectively closes the substrate binding cavity. The inability to bind glutathione in the post-
hydrolysis state enforces the unidirectionality of the transport cycle, since the binding site only exists 
during the transition from the inward to outward facing conformations. 
 
Other ABC transporter systems, such as the oligosaccharide flippase, PglK, the multidrug resistance 
protein, TmrAB, and the drug efflux pump ABCB1 (P-glycoprotein), also exhibit changes in TM6 
kinking and binding between distinct conformational states (Figure S9). The detailed progression of 
changes in TM6 vary between the different transporters, however, and NaAtm1 is so far unique in 
the nearly straight TM6s present in the occluded structure. The coupling of TM6 to substrate binding 
observed with NaAtm1 has also been noted for other transporters. From the analysis of multiple 
TmrAB structures, TM6 of each subunit was identified as the gatekeeper controlling access to 
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substrate binding cavities (Hofmann et al. 2019), while in ABCB1 (Alam et al. 2018), TM6 and 
TM12 (equivalent to TM6 in a full ABC transporter), were found to be important in substrate 
binding, along with TM4 and TM10. Rather than a universal set of structural changes associated 
with the transport cycle, however, each system will have its own distinct structural features. Thus, 
detailed characterizations of the different intermediate states of a specific transporter are essential 
for addressing its transport mechanism.  
 
The structural and functional characterization of the disulfide crosslinked variants revealed several 
unanticipated findings that reflect the apparent the plasticity of the NBD-NBD interface. The 
structures of the two disulfide crosslinking variants, NaA527C and NaS526C, determined in this 
study included three different conformational states, the two inward-occluded conformations of 
NaA527C and the occluded conformation of NaS526C. Unexpectedly, the disulfide crosslinked 
NaS526C variant not only hydrolyzed ATP, but could also transport substrate (Figure 2). While the 
presence of a disulfide crosslink between the NBDs might be expected to inhibit the functionality by 
restricting relevant conformational changes, the observation that this variant is transport competent 
indicates that ATP hydrolysis and substrate transport involve a limited set of conformational states 
that do not require wide separation of the NBDs.  
 
The characterization of NaAtm1 in multiple conformational states provides the opportunity to outline 
the structural changes that occur in the transport cycle. Since each structure represents a separate 
experiment determined under different conditions, it is not possible to unambiguously order the 
structures in a sequence along the transport cycle. With the introduction of several assumptions about 
the relationships between structures, however, a working model for a structure-based transport 
mechanism of NaAtm1 can be devised. These assumptions are: i) the available NaAtm1 structures 
approximate on-path intermediates, ii) the transported ligand binds preferentially to the inward-
facing conformation (Lee et al. 2014, Srinivasan, Pierik, and Lill 2014) and iii) the outward-facing 
conformation is stabilized by ATP (see (Dawson and Locher 2006, Kim and Chen 2018, Stefan, 
Hofmann, and Tampe 2020)), with return to the inward-facing conformation accompanying Pi 
dissociation (Hofmann et al. 2019). A schematic mechanism for substrate-dependent transport by 
NaAtm1 is presented in Figure 5 (top), with the main features summarized as follows. Substrate and 
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MgATP can bind to the transporter in both the inward-facing and inward-facing occluded states. 
The transition from the inward-facing to outward-facing conformation through the occluded states 
is accompanied by ATP binding. The progression from the inward-facing to outward-facing 
conformations is reflected in the straightening of TM6, which alters the GSSG binding site, creating 
the larger cavity of the occluded conformation, and ultimately leading to dissociation from the 
outward-facing conformation. Although we were unable to capture an outward facing conformation 
by either x-ray crystallography or electron microscopy, it is possible that the flexibility of the 
periplasmic loops observed in the occluded conformation may transiently open an exit pathway for 
glutathione release. On resetting to the inward conformation, regeneration of kinked TM6 helices 
creates a closed conformation by eliminating the substrate binding cavity as trapped in the post-
hydrolysis MgADPVO4 trapped state. Although we have only observed symmetric NaAtm1 
structures, we cannot exclude the presence of asymmetric states as observed for TmrAB (Hofmann 
et al. 2019). Upon Pi dissociation, the transporter returns to the inward-facing and/or the inward-
facing occluded states, and the transporter is ready for the next transport cycle.  
 
A key question for ABC exporters centers on the role of the substrate in the transport cycle; given 
the observed basal ATPase activities, there is not an obligatory coupling between the ATPase activity 
and substrate binding/transport. This is a surprising situation given what is known for the transport 
cycles of well-coupled transporters such as lac permease (Kaback 2015) and P-type ATPases 
(Palmgren and Nissen 2011), where both the transported substrate and the energy source (H+ or ATP, 
respectively) must be present for translocation to proceed. As depicted in Figure 5 (bottom), the 
uncoupled activity could reflect the operation of a parallel, but distinct, pathway for ATP hydrolysis 
that occurs in the absence of the transported substrate, as proposed for certain ABC importers 
(Lewinson and Livnat-Levanon 2017) and ABC exporters (Hofmann et al. 2019). A key intermediate 
for understanding the coupling mechanism of an ABC exporter is the occluded state with both 
substrate and ATP bound (Figure 5); this state has not been captured for NaAtm1 or, to our 
knowledge, for any other ABC exporter. This particular species perhaps exists only transiently before 
the substrate dissociates from the outward-facing conformation (also likely a transiently occurring 
state (Hofmann et al. 2019, Grossmann et al. 2014)), even in the transport-competent form with the 
disulfide linked NBDs. Engineering a construct adopting an occluded conformation with both 
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substrate and ATP bound will be a priority for future investigations to address the coupling 
mechanism of NaAtm1. 
 
2.6 Material and Methods 
Mutagenesis and protein expression  
The gene encoding NaAtm1 (with GenBank accession code ABD27067) was previously cloned into 
a pJL-H6 ligation independent vector with 6-His tag on the carboxy-terminus (Lee et al. 2014), and 
deposited in Addgene with catalog #78308. All mutants were generated using Q5 Site-Directed 
Mutagenesis Kit (New England Biolabs). All native proteins were overexpressed in Escherichia coli 
BL21-gold (DE3) cells (Agilent Technologies) using ZYM-5052 autoinduction media and all the 
selenomethionine substituted proteins were overexpressed in Escherichia coli B834 (DE3) cells 
(Novagen) using PASM-5052 autoinduction media as described previously (Lee et al. 2014). Cells 
were collected by centrifugation and stored at -80 ˚C until use.  
 
Purification and crosslinking  
Frozen cell pellets of cysteine mutants were resuspended in lysis buffer containing 100 mM NaCl, 
20 mM Tris, pH 7.5, 40 mM imidazole, pH 7.5, 5 mM β-mercaptoethanol (BME), 10 mM MgCl2, 
0.5% (w/v) n-dodecyl-β-D-maltopyranoside (DDM) (Anatrace), 0.5% (w/v) octaethylene glycol 
monododecyl ether (C12E8) (Anatrace), lysozyme, DNase, and protease inhibitor tablet. The 
resuspended cells were lysed either by solubilizing by stirring for 3 hours at 4 ˚C, or by using a M-
110L pneumatic microfluidizer (Microfluidics). Unlysed cells and cell debris were removed by 
ultracentrifugation at ~113,000x g for 45 minutes at 4 ˚C. The supernatant was collected and loaded 
onto a prewashed NiNTA column with NiNTA wash buffer at 4 ˚C. NiNTA wash buffer contained 
100 mM NaCl, 20 mM Tris, pH 7.5, 50 mM imidazole, pH 7.5, 5 mM BME, 0.05% DDM and 0.05% 
C12E8. Elution was achieved using the same buffer containing 350 mM imidazole instead. The 
eluted protein was then buffer exchanged to 100 mM NaCl, 20 mM Tris, pH 7.5, 0.05% DDM and 
0.05% C12E8 (SEC buffer). Oxidation of engineered cysteines to form disulfide bonds was achieved 
by incubating buffer exchanged protein with 1 mM Cu (II) (1,10-phenanthroline)3 for 1 hour at 4 ˚C. 
Crosslinked sample was buffer exchanged into SEC buffer to remove the oxidant, and further 
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purified by size exclusion chromatography (SEC) using HiLoad 16/60 Superdex 200 (GE 
Healthcare). Fractions were pooled and concentrated to 20-35 mg/mL using an Amicon Ultra 15 
concentrator (Millipore) with a molecular weight cutoff of 100 kDa. Wild type NaAtm1 was 
solubilized in lysis buffer containing 1% DDM and purified in NiNTA and SEC buffers containing 
0.1% DDM for crystallization in the occluded conformation with MgAMPPNP.  
 
Crystallizations 
NaA527C was crystallized in MemGold (Molecular Dimensions) condition #68. Upon optimization 
of the crystallization conditions, including the use of additive screens (Hampton Research), the best 
crystals were grown from 100 mM NaCl, 100 mM Tris, pH 8.3, 25 mM MgCl2, and 28% 
polyethylene glycol 2,000 monomethyl ether (PEG 2,000 MME) with 20 mM ATP, pH 7.5 at 20 ˚C. 
NaA527C crystallization sample was prepared at 20 mg/mL with 1 mM ATP, pH 7.5, 5 mM EDTA, 
pH 7.5 and with or without 5 mM GSSG, pH 7.5. Crystals appeared in about 2 weeks and lasted for 
about a month. Crystals were harvested in cryoprotectant solutions containing 100 mM NaCl, 100 
mM Tris, pH 8.3, 25 mM MgCl2, 28% PEG 2,000 MME with PEG 400 at 10%, 15%, and 20% 
before flash-freezing in liquid nitrogen.  
 
NaS526C, NaT525C and NaE523Q crystals were prepared in the same condition as NaA527C 
except the removal of MgCl2 in the crystallization well solution. All crystallization samples were 
prepared with 1 mM ATP, pH 7.5 and 5 mM EDTA, pH 7.5. The crystallization condition of 
NaT525C was further optimized with 200 mM of NDSB-221 using the Additive Screen (Hampton 
Research). The crystallization condition of NaE523Q was further optimized with 10 mM 
dithiothreitol but without 20 mM ATP, pH 7.5 in the crystallization conditions. Crystals of all three 
constructs were harvested in cryoprotectant solutions containing 100 mM NaCl, 100 mM Tris, pH 
8.3, 28% PEG 2,000 MME with PEG 400 at 10%, 15%, and 20% before flash-freezing in liquid 
nitrogen.  
 
NaAtm1 purified in DDM was crystallized in MemChannel (Molecular Dimensions) condition #29. 
The crystallization sample was prepared with 1 mM AMPPNP, pH 7.5, 2 mM MgCl2, and either 
with or without 5 mM GSSG, pH 7.5. The condition was further optimized to 50 mM ADA, pH 7.1, 
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8-10% PEG 1000 and 8-10% PEG 1500 at 20˚C with protein at 8 mg/ml. Crystals appeared within 
a week and were harvested in cryoprotectant solutions containing 50 mM ADA, pH 7.1, 10% PEG 
1000 and 10% PEG 1500 with PEG400 at 10%, 15%, and 20% before flash-freezing in liquid 
nitrogen. 
 
X-ray data collection and structure determinations  
X-ray datasets were collected at the Stanford Synchrotron Radiation Laboratory beamline 12-2 using 
a Pilatus 6M detector with Blu-Ice interface (McPhillips et al. 2002) and Advanced Photon Source 
GM/CA beamline 23ID-B using an Eiger 16M detector with JBluIce-EPICS interface (Stepanov et 
al. 2011). All datasets were processed and integrated with XDS (Kabsch 2010) and scaled with 
Aimless (Winn et al. 2011). For the NaA527C crystal structure, the first three transporters in the 
asymmetric unit were identified by searching for multiple copies of the TMDs and NBDs using the 
inward-facing structure (PDB ID: 4MRN) with Phaser in Phenix (Adams et al. 2010). Due to the 
relatively poor electron density for the fourth transporter, the helices of the TMDs were first built 
using Find Helices and Strands in Phenix (Adams et al. 2010), then a full transporter from the 
previously identified partial model was superposed onto the built helices in Coot (Emsley et al. 
2010), which resulted in the misplacement of one NBD. The misplaced NBD was removed from the 
model and was subsequently correctly placed using Molrep in CCP4 (Winn et al. 2011). For the 
NaS526C structure, molecular replacement was carried out using Sav1866 (PDB ID: 2HYD) with 
superposed NaAtm1 sequence as the input model for Phaser in Phenix (Adams et al. 2010). For the 
NaT525C, NaE523Q and NaAtm1 structures, molecular replacement was carried out using the 
NaS526C structure as the input model for Phaser in Phenix (Adams et al. 2010). For all structures, 
experimental phase information was derived from SeMet datasets by MR-SAD using AutoSol in 
Phenix (Adams et al. 2010). Iterative refinement and model building cycles were carried out with 
phenix.refine in Phenix (Adams et al. 2010), Refmac in CCP4 (Winn et al. 2011) and Coot (Emsley 
et al. 2010). The final refinements were performed with phenix.refine in Phenix (Adams et al. 2010). 
 
Single particle sample and grid preparation 
The expression plasmid for the membrane scaffolding protein (MSP1D1) was purchased from 
Addgene (plasmid #20061) and its expression and purification were carried out using published 
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protocols (Ritchie et al. 2009). The reconstitutions were performed with 1-palmitoyl-2-oleoyl-
glycero-3-phosphocholine (POPC) (Avanti Lipids) at a ratio of NaAtm1: MSP1D1: POPC = 1:(2-
4):130. For the structure with MgADPVO4 bound, MSP1D1 and POPC were added after incubating 
detergent purified protein with 4 mM MgCl2, 4 mM ATP, pH 7.5, and 4 mM VO43- for 4hrs to allow 
for ATP hydrolysis at 4˚C. VO43- was prepared from sodium orthovanadate following a published 
protocol (Oldham and Chen 2011). The reconstituted samples were incubated overnight at 4 ˚C with 
BioBeads addition at 400 mg/ml for detergent removal. The samples were subjected to size exclusion 
chromatography with Superdex 200 Increase 10/300 (GE Healthcare). Peak fractions were either 
pooled and concentrated or directly used for grid preparation. Grids were prepared with protein 
concentrations between 0.6 to 4 mg/mL. Briefly, 3 µL of protein solution was applied to freshly glow 
discharged UltrAuFoil 2/2 200 mesh grids (MgADPVO4 stabilized closed conformation) and 
QuantiFoil Au R1.2/1.3 200 mesh grids (inward-facing conformation), blotted for 4 seconds with 0 
blot force and 100% humidity at room temperature using Vitrobot Mark IV (FEI).  
 
Single-particle data collection, processing and refinement 
For the MgADPVO4 stabilized closed conformation, two datasets were collected with a Gatan K3 
direct electron detector on a 300 keV Titan Krios in the super-resolution mode using SerialEM. For 
data collection, a total dosage of 60 e-/Å2 was utilized, with a defocus range between -1.5 to -3.5 µm 
at the Caltech CryoEM facility, and a total dosage of 48.6 e-/Å2 with a defocus range between -1.7 
to -2.4 µm at the Stanford-SLAC Cryo-EM Center (S2C2). The two datasets were processed 
separately. For the inward-facing conformation, data was collected with a Gatan K2 Summit direct 
electron detector on a 300 keV Titan Krios in the super-resolution mode using EPU with a total 
dosage of 36 e-/Å2 with a defocus range between -1.0 to -3.5 µm at the Caltech CryoEM facility.  
 
Processing of all single particle datasets was performed with cryoSPARC 2 (Punjani et al. 2017), 
using patch-motion for motion correction and estimating the CTF parameters with CTFFIND 
(Rohou and Grigorieff 2015). Particles were picked using either a previous reconstruction of 
NaAtm1 or a blob as template, and then extracted. Rounds of 2D classifications were performed, 
leaving ~170K particles for the MgADPVO4 stabilized closed conformation using data from the 
S2C2 collection and ~100K particles for the inward-facing conformation for the 3D reconstruction. 
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The resulting 3D reconstructions were then refined with homogeneous and non-uniform 
refinements in cryoSPARC 2 (Punjani et al. 2017). For the MgADPVO4 stabilized closed structure, 
local CTF refinement was carried out to refine per-particle defocus, and the final local refinement 
was performed using symmetry expanded (C2) particles in cryoSPARC 2 (Punjani et al. 2017) along 
with a mask generated in Chimera (Pettersen et al. 2004) based on a fitted model.  
 
Initial model fitting was carried out with phenix.dock_in_map in Phenix (Adams et al. 2010) using 
a single chain of the MgAMPPNP bound occluded structure (PDB ID: 6PAR) as the starting model 
for the MgADPVO4 bound closed structure, and a single chain of the inward-facing conformation 
(PDB ID: 4MRN) for the wide open inward-facing conformation. Model building and ligand fitting 
were manually carried out in Coot (Emsley et al. 2010) and the structures were iteratively refined 
using phenix.real_space_refine in Phenix (Adams et al. 2010).  
 
Proteoliposome preparation and transport assay  
Proteoliposomes (PLS) were prepared by following the published protocol for ABC transporter PLS 
reconstitution using Escherichia coli polar lipid extract and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) (Avanti Lipids) (Geertsma et al. 2008), with an additional step of Biobeads 
addition at 40 mg/ml to ensure the complete removal of detergents. The transport assay was 
conducted with NaAtm1 reconstituted in PLS in a 1 mL format at 37 °C. The reaction mixture 
contained PLS at 5 mg/mL, 10 mM MgATP, pH 7.5, 2.5 mM GSSG, pH 7.5, and transport buffer at 
85 mM NaCl, and 17 mM Tris, pH 7.5. The different controls were also prepared in a similar fashion. 
150 µL aliquots of the reaction mixture were taken every 15 minutes, added to 1 ml cold transport 
buffer, and then ultracentrifuged at ~203,000g in a TLA 100.3 rotor in a Beckman Ultima benchtop 
ultracentrifuge for 10 minutes at 4 °C. The pellets were washed 10 times with cold transport buffer, 
and then resuspended to 100 µl with solubilization buffer (85 mM NaCl, 17 mM Tris, pH 7.5 and 
2% sodium dodecanoyl sarcosine (Anatrace)). The samples were solubilized for 2 hours until the 
solution clarified before spinning down in the TLA 100 rotor to remove bubbles. 10 µL samples 
were taken for GSSG quantification using the Glutathione Quantification Assay (Sigma-Aldrich). 
Reactions were done in triplicates and the rates were not corrected for orientation effects of NaAtm1 
in PLS.  
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ATPase assay  
The ATPase activity was determined by the molybdate-based phosphate quantification method 
(Chifflet et al. 1988). All reactions were performed in a 250 µL scale with a final protein 
concentration of 0.05 mg/ml for both PLS and detergent, at various concentrations of MgATP and 
GSSG, pH 7.5 at 37 °C. 50 µL of reaction were taken every 5 minutes for 4 times, mixed with 50 
µL of 12% SDS in a 96-well plate at room temperature. 100 µL of ascorbic acid/molybdate mix was 
added, incubated for 5 minutes before the addition of 150 µL of citric acid/arsenite/acetic acid 
solution. The reaction was then incubated for 20 minutes at room temperature before reading at 850 
nm with a Tecan plate reader. Reactions were done in triplicates, the measurements were plotted 
against time, and the final linear rates were fitted with nonlinear regression fit using Prism 8. The 
rates were not corrected for orientation of NaAtm1 in PLS. 
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2.8 Figures 
 
 
Figure 1. NaAtm1 structure overview. 
Crystal structures of NaA527C in the inward-facing occluded conformation in (a) state #1, and (b) 
state #2, both with MgADP bound. Crystal structures of (c) NaS526C, (d) NaT525C and (e) 
NaE523Q in the occluded conformation, all with ATP bound. (f) Crystal structure of NaAtm1 in an 
occluded conformation with MgAMPPNP bound. (g) Single particle cryo-EM structure of NaAtm1 
in a closed conformation with MgADPVO4 bound. (h) Single particle cryo-EM structure of NaAtm1 
in a wide-open inward-facing conformation. All structures are colored with one chain in grey and 
the second chain in yellow, red, blue, purple, pink, orange, green, and cyan, respectively. Nucleotides 
are shown in sticks with Mg2+ shown as green spheres.  
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Figure 2. NaAtm1 transport and ATPase activities.  
ATPase activities of NaAtm1 and its variants at 10 mM MgATP in the absence and presence of 
2.5 mM GSSG, in (a) detergent and (b) PLS. (c) Wild type NaAtm1 transport activities with 
various controls at 10 mM MgATP and 2.5 mM GSSG. (d) Transport activities of NaAtm1 and its 
variants with 10 mM MgATP and 2.5 mM GSSG. Error bars represent the standard errors of the 
means and circles represent the results of individual measurements. All measurements shown were 
done in triplicate. The individual rate measurements for the ATPase and transport activities are 
presented in Tables S2 and S3. 
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Figure 3. Comparison of the central cavities for the NaAtm1 structures.  
Surface representations of the overall structures and internal binding cavities for (a) NaAtm1 wide-
open inward-facing conformation, (b) NaAtm1 inward-facing conformation (PDB ID: 4MRN), (c) 
NaA527C inward-facing occluded state #1, (d) NaA527C inward-facing occluded state #2, (e) 
NaS526C occluded conformation, (f) NaT525C occluded conformation, (g) NaE523Q occluded 
conformation, (h) NaAtm1 MgAMPPNP bound occluded structure, and (i) NaAtm1 MgADPVO4 
bound closed structure. (j) Surface representation of the overall structure and central binding cavity 
of Sav1866 in the outward-facing conformation (PDB ID: 2HYD). The cavity of NaAtm1 wide-
open inward-facing structure is shown in cyan, NaAtm1 inward-facing structure is shown in gray, 
NaA527C inward-occluded structure #1 in yellow, NaA527C inward-occluded structure #2 in red, 
NaS526C occluded structure in blue, NaT525C occluded structure in purple, NaE523Q occluded 
structure in pink, NaAtm1 MgAMPPNP occluded structure in orange, and Sav1866 outward-
facing structure in brown. The volumes of the cavities were all calculated by CastP (Tian et al. 
2018) with a probe radius of 2.5 Å.   
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Figure 4. TM6 comparisons of NaAtm1.  
(a) TM6 (residues 300-340) conformations observed in different NaAtm1 structures. (b) Hydrogen 
bonding interactions between GSSG and TM6 main chain groups from residues in the kink region 
of the primary binding site (residues 316-320; (PDB ID: 4MRS)). Hydrogen bonding interactions 
are shown in yellow dashes and GSSG is shown in ball and sticks. (c) Potential interactions 
between GSSG and residues 316-320 in other NaAtm1 structures. The approximate location of 
GSSG is obtained from the structural alignments of TM6s in different structures to the TM6 of the 
inward-facing conformation of NaAtm1 (PDB ID: 4MRS). TM6s in the NaAtm1 wide-open 
inward-facing structure are shown in cyan, NaA527C inward-occluded structure #1 in yellow, 
NaA527C inward-occluded structure #2 in red, NaS526C occluded structure in blue, NaT525C 
occluded structure in purple, NaE523Q occluded structure in pink, NaAtm1 MgAMPPNP bound 
occluded structure in orange, and NaAtm1 MgADPVO4 bound closed structure in green. 
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Figure 5. Schematic representation of a structure-based transport mechanism for NaAtm1.  
The substrate-dependent (transport, top cycle) and substrate-independent (bottom cycle) ATPase 
pathways differ by the presence or absence of bound substrate, respectively, during the transition 
from the inward- to outward-facing conformation. Resetting the outward-facing to the inward-facing 
conformation involves a set of intermediates common to both pathways, including the closed, post-
hydrolysis conformation lacking a substrate binding site. Ligand binding to disulfide crosslinked 
variants may occur in the inward-occluded conformations (green arrows), without accessing the fully 
inward-facing conformations. Inward-facing and inward-facing occluded structures have been 
determined in both apo and substrate bound states (PDB IDs: 6VQU (wide-open), 4MRN (apo), 
4MRS (GSSG bound), 4MRP (GSH bound), 4MRV (GS-Hg bound) and 6PAM (MgADP bound)). 
The inward-occluded state with both substrate and ATP present is modeled on the crystal structure 
of the inward-facing occluded structure with MgADP bound (PDB ID: 6PAM). The ATP bound 
occluded state has been determined for the disulfide crosslinking mutants (NaS526C and NaT525C 
with PDB IDs: 6PAN and 6PAO, separately), the ATP hydrolysis deficient mutant (NaE523Q with 
PDB ID: 6PAQ) and the wild type transporter with MgAMPPNP bound (PDB ID: 6PAR). The 
outward-facing conformation of NaAtm1 has not been structurally characterized, but its presence is 
essential for substrate release. The post-hydrolysis closed state has been characterized with 
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MgADPVO4 bound (PDB ID: 6VQT), while the ADP bound occluded state after ATP hydrolysis 
has been solved with NaA527C (PDB ID: 6PAM). Asterisks denote the structurally characterized 
structures to date for NaAtm1.  
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2.9 Supplemental Information 
 
 
Figure S1. Screening candidate residues in NaAtm1 for disulfide crosslinking.  
(a) Partial sequence alignments of NBDs of various ABC transporters. (b) SDS-PAGE of the 
products of crosslinking with Cu (II) (1,10-phenanthroline)3 under different conditions for the three 
cysteine variants in this report. RT = room temperature, SS = crosslinked species, SH = 
uncrosslinked (disulfide reduced) species. 
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Figure S2. NaA527C inward-facing occluded structures.  
(a) Location of selenium sites in the four transporters present in the selenomethionine-substituted 
NaA527C asymmetric unit. The selenium sites identified in AutoSol of Phenix (Adams et al. 2010) 
are shown in red spheres, the sulfur atoms of methionine residues from the refined model are shown 
in yellow spheres, and nucleotides are shown in sticks with Mg2+ shown in green spheres. (b) 
Disulfide bridges in the four transporters in the asymmetric unit. The Ca positions corresponding to 
C527 in the two chains are depicted as grey and yellow spheres for transporters #1-3, and grey and 
red spheres for transporter #4, separately. (c) Composite omit map calculated from Phenix (Adams 
et al. 2010) showing the electron density for the bound MgADP in different chains of NaA527C in 
the asymmetric unit. Nucleotides are shown in sticks with Mg2+ shown as green spheres.  
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Figure S3. Structural alignments of NaA527C in the inward-facing occluded conformations.  
(a) Alignment of NaA527C inward-facing occluded conformation #1 (yellow) to NaA527C inward-
facing occluded conformation #2 (red) with an overall RMSD of 1.7 Å. The relative rotation of 
the a-helical domains in the NBDs between the two states is shown in (b). (c) Alignment of 
NaA527C inward-facing occluded conformation #1 to NaAtm1 inward-facing conformation (PDB 
ID: 4MRN) (grey) with an overall RMSD of 2.1 Å. (d) Alignment of NaA527C inward-facing 
occluded conformation #2 (red) to NaAtm1 inward-facing conformation (PDB ID: 4MRN) (grey) 
with an overall RMSD of 4.4 Å. Nucleotides are shown in sticks with Mg2+ shown as green spheres. 
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Figure S4. Binding of GS-Hg to NaA527C inward-facing occluded structures. 
Anomalous electron density maps calculated from data collected at the Hg edge, contoured at the 5 
s levels (dark blue) for NaA527C crystallized in the presence of GS-Hg. For comparison, the 
structure of NaAtm1 with GS-Hg bound (PDB ID: 4MRV) is indicated (left) with mercury shown 
in purple sphere. 
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Figure S5. NaAtm1 in the occluded conformations.  
(a) Disulfide bridge formed by S526C in the NaS526C structure with the Ca positions shown as 
grey and blue spheres. (b) Composite omit map calculated from Phenix (Adams et al. 2010) showing 
the electron density for the bound ATP in the dimeric NaS526C structure. (c) T525C residues in the 
NaT525C occluded structure with the Ca positions shown as grey and purple spheres. (d) Composite 
omit map showing the electron density for the bound ATP in the dimeric NaT525C structure. (e) 
Composite omit map calculated from Phenix (Adams et al. 2010) showing the electron density for 
the bound ATP in the dimeric NaE523Q structure. (f) NaT525C overall structural alignment to 
NaS526C with an RMSD of 0.5 Å. (g) NaE523Q overall structural alignment to NaS526C with an 
RMSD of 0.5 Å. (h) NaE523Q overall structural alignment to NaT525C with an RMSD of 0.7 Å. 
NaS526C is colored in blue, NaT525C in purple, and NaE523Q in pink. Nucleotides are shown in 
sticks.   
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Figure S6. Structural alignments of NaAtm1 with MgAMPPNP bound in the occluded 
conformation.  
(a) Composite omit map calculated from Phenix (Adams et al. 2010) showing the electron density 
for the bound MgAMPPNP in the three copies of NaAtm1 in the asymmetric unit. NaAtm1 occluded 
structure alignments to (b) NaS526C with an overall RMSD of 1.1 Å, (c) NaT525C with an overall 
RMSD of 0.9 Å, and (d) NaE523Q with an overall RMSD of 1.1 Å. NaAtm1 occluded structure 
colored in orange, NaS526C in blue, NaT525C in purple and NaE523Q in pink. Nucleotides are 
shown in sticks with Mg2+ shown as green spheres.   
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Figure S7. Single particle cryo-EM structure of NaAtm1 in the closed conformation stabilized 
with MgADPVO4.  
(a) Examples of 2D classes. (b) Fourier shell correlation (FSC) curve showing the resolution estimate 
for the final reconstruction, generated from the final refinement in cryoSPARC 2 (Punjani et al. 
2017). (c) Density fitting for different TM helices and nucleotides (MgADPVO4). Overall structural 
alignments to the occluded structures of (d) NaS526C, (e) NaT525C, (f) NaE523Q and (g) NaAtm1 
occluded crystal structures with RMSDs of 2.0 Å, 2,1 Å, 2.0 Å and 1.7 Å, respectively. Nucleotides 
are shown in sticks with Mg2+ shown as green spheres.    
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Figure S8. Single particle cryo-EM structure of NaAtm1 in the wide-open inward-facing 
conformation.  
(a) Examples of 2D classes. (b) FSC curve showing the resolution estimate for the final 
reconstruction, generated from the final refinement in cryoSPARC 2 (Punjani et al. 2017). (c) 
Density fitting for different TM helices. Overall structural alignments to (d) NaAtm1 inward-facing 
conformation (PDB ID 4MRN), (e) NaA527C inward-facing occluded state #1, and (f) NaA527C 
inward-facing occluded state #2 crystal structures with RMSDs of 5.8 Å, 8.9 Å, and 9.3 Å, 
respectively. Nucleotides are shown in sticks with Mg2+ shown as green spheres.   
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Figure S9. TM6 comparisons for different ABC transporter systems.  
(a) TM6 (residues 300-340) arrangements of representative NaAtm1 structures. (b) TM6 (residues 
288-335) arrangements of representative PglK structures. (c) TM6 (residues 290-333 of chain A and 
residues 275-319 of chain B) arrangements of representative TmrAB structures. (d) TM6 (residues 
324-370 and residues 968-1013) arrangements of representative ABCB1 structures. The 
corresponding PDB IDs and the conformational states are labeled below the structures.   
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Table S1. Coupling efficiencies between ATP hydrolysis and substrate translocation for 
ABC transporters.  
Coupling efficiencies for different transport systems (Zehnpfennig, Urbatsch, and Galla 2009, 
Davidson and Nikaido 1990, Patzlaff, van der Heide, and Poolman 2003, Lycklama et al. 2018, 
Eytan, Regev, and Assaraf 1996, Wang et al. 2006, Dean, Davidson, and Nikaido 1989, Dong, Penin, 
and Baggetto 1996, Nikaido and Ames 1999, Manolaridis et al. 2018, Hofmann et al. 2019, Borths 
et al. 2005, Woo et al. 2012, Chen et al. 2001, Chavan et al. 2013). Coupling efficiencies are either 
presented in the corresponding reference or calculated based on the reported ATPase and transport 
activities of the transporter. Coupling efficiency = ATPase activity/transport activity. 
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Table S2. Raw ATPase activities of NaAtm1 and variants in both proteoliposomes and 
detergent.  
The ATPase activities were measured in triplicate at 10 mM MgATP and 2.5 mM GSSG at 37 °C. 
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Table S3. Raw transport activities of NaAtm1 and variants.  
The transport activities for various controls and the different NaAtm1 variants were measured in 
triplicate at 10 mM MgATP and 2.5 mM GSSG at 37 °C.  
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Table S4. Data collection and refinement statistics of NaA527C 
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Table S5. Data collection and refinement statistics of NaS526C 
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Table S6. Data collection and refinement statistics of NaT525C 
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Table S7. Data collection and refinement statistics of NaE523Q
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Table S8. Data collection and refinement statistics of NaAtm1 
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Table S9. Cryo-EM data collection, refinement and validation statistics 
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C h a p t e r  3  
A KINETIC MODEL FOR THE ATPASE STIMULATION OF THE ABC 
EXPORTER NAATM1 BY THE TRANSPORTED SUBSTRATE GSSG 
This chapter is adapted from:  
Fan, C., and Rees, D.C. “A kinetic model for the ATPase stimulation of the ABC exporter 
NaAtm1 by the transported substrate GSSG.” In preparation. 
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3.1 Abstract  
Previous structural analysis on a bacterial homolog of the eukaryotic ABC transporter of 
mitochondria from Novosphingohium aromaticivorans (NaAtm1) outlined a conformational 
framework for both the substrate-dependent transport cycle and the substrate-independent ATPase 
cycle. Here, we report the characterization of the ATPase activities of NaAtm1 in the absence and 
presence of a transported substrate, oxidized glutathione (GSSG), in detergent, nanodiscs and 
proteoliposomes. The basal ATPase activities of NaAtm1 were significantly stimulated by 
increasing concentrations of GSSG, although the details varied between the different samples, 
highlighting the importance of the detailed lipid environment for NaAtm1 function. Changes in the 
apparent Michaelis-Menten constant KM for MgATP with changes in GSSG concentration were also 
observed. The kinetic data were fit to the “non-essential activator model” where the basal ATPase 
rate of the transporter is stimulated by the transported substrate, which consequently functions as an 
ATPase activator. An expanded non-essential activator kinetic model with two GSSG binding sites 
recapitulated the dependence of the turnover rate and apparent MgATP binding affinity on GSSG 
concentration. 
 
3.2 Introduction 
Membrane transporters couple the translocation of ligands to a thermodynamically favorable driving 
force. A key feature of the transport mechanism is that these two processes - ligand transport and the 
driving force - must be linked to minimize “short circuiting” of the transduction process (Tanford 
1983, Hill 1989). In essence, transporters kinetically facilitate the coupled reaction while disfavoring 
the individual uncoupled reactions. One way to achieve coupling between the favored and unfavored 
reactions is when both processes proceed through a common set of conformational states so that they 
can only be accessed when the relevant components are both present (Rees and Howard 1999). 
Structure based mechanisms defining these coupling processes have been advanced for several 
transporters, including lactose permease (Kaback 2015) and P-type ATPases (Palmgren and Nissen 
2011). 
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ATP Binding Cassette (ABC) transporters form a large family where substrate translocation is 
coupled to the ATPase activity (Higgins 1992, Rees, Johnson, and Lewinson 2009, Locher 2016). 
Of note, they typically exhibit significant basal ATPase activity in the absence of transported 
substrates (i.e. uncoupled ATPase activity). The presence of transported substrates stimulates the 
ATPase activity and indeed, putative substrates for ABC exporters are commonly identified as 
ATPase activators, although these molecules may not necessarily be the transported substrate 
(Lefevre and Boutry 2018). Our previous structural analyses on a bacterial ABC exporter from 
Novosphingobium aromaticavorans (NaAtm1) identified multiple conformational states, including 
the inward-facing, outward-facing and various occluded states in the presence of different 
nucleotides. In addition to the substrate-dependent transport cycle, there also exists a substrate 
independent ATPase cycle responsible for the basal activity of the transporter. To gain more insights 
into the substrate dependent transport cycle, we measured the substrate dependent ATPase activities 
of NaAtm1 in detergent, nanodiscs (ND), and proteoliposomes (PLS). The reconstructed equilibrium 
kinetic model revealed interesting findings for the ATP dependent substrate translocation. 
 
3.3 Results 
Michaelis-Menten kinetics 
To measure the ATPase activities of NaAtm1 in different membrane-like environments, we 
reconstituted detergent purified protein into both nanodiscs (ND) formed by membrane scaffolding 
proteins and proteoliposomes (PLS), using previously described protocols. The ATPase rates were 
measured under varying concentrations of MgATP and GSSG, by quantifying the amount of 
inorganic phosphate (Pi) released upon ATP hydrolysis using a molybdate-based colorimetric assay 
(Chifflet et al. 1988). In contrast to NaAtm1 solubilized in detergent (Figure 1a) or reconstituted into 
ND (Figure 1b), NaAtm1 in PLS presents an orientational issue, with the NBDs either positioned 
outside the PLS (and accessible to the assay) or positioned inside the PLS (and inaccessible to the 
assay). If there is no orientational preference in the reconstitution process, then 50% of the 
transporters will adopt each orientation. As this effect was not experimentally investigated, we do 
not have independent confirmation of the orientation factor and so the measured ATPase activities 
in PLS for NaAtm1 are not corrected for this effect. 
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The measured ATPase activities of NaAtm1 in the presence of a fixed concentration of GSSG were 
fit to the Michaelis-Menten equation (Figure 2). From these fits, values for the observed turnover 
rate kobs and the apparent binding constant for MgATP binding KT (KM for MgATP) were obtained 
at various concentrations of GSSG, summarized in Table 1. In all three environments (detergent, ND 
and PLS), the ATPase activities exhibit dependence on the concentration of GSSG in a dose-
dependent manner. In the absence of GSSG, the maximal rates (Vmax) of ATP hydrolysis were 
extrapolated to 135, 170 and 70 nmol Pi min-1 mg-1 transporter in detergent, ND and PLS, 
corresponding to turnover rates of 18.0, 22.6, and 9.5 min-1 per dimeric NaAtm1, respectively. 
(Figure 2, Table 1a). At the highest concentration of GSSG that the ATPase activities were measured 
(20 mM), about eight times of the physiological GSSG concentration (Bennett et al. 2009), the 
maximum extrapolated ATPase activity for NaAtm1 in detergent was ~700 nmol Pi min-1 mg-1, by 
stimulating its corresponding basal activity to ~5 times, 2400 nmol Pi min-1 mg-1 for NaAtm1 in ND 
with ~14 times of basal activity stimulation, and 800 nmol Pi min-1 mg-1 for NaAtm1 in PLS with 
~11 times of basal activity stimulation (Figure 2). As the orientation effect in PLS was not taken into 
account, the actual ATPase rate in PLS may be ~2 times of the measured activity.  
 
Basic non-essential activator kinetic model 
Both kobs, the observed turnover rate, and KT, the Michaelis-Menten constant for MgATP, depend 
on the concentration of the transported substrate GSSG. To model this data, we used a non-essential 
activator model (Figure 3a) where the transported substrate GSSG is an activator that stimulates the 
ATPase rate above the basal level (Segel 1975, Baici 2015). The key kinetic parameters in this model 
are: i) KT, the binding constant for MgATP; ii) KS, the binding constant for the transported substrate, 
GSSG, which is also an activator of the ATPase rate, iii) a, the interaction factor for how binding of 
MgATP influences the binding of GSSG (and vice versa). The convention is that a < 1 or > 1 denotes 
positive and negative cooperativity, respectively; iv) k, the basal rate constant for MgATP hydrolysis 
in the absence of GSSG and v) b, the acceleration factor for MgATP hydrolysis with bound GSSG. 
In this model, the ATPase sites are treated as independent since the dependence of the ATPase rate 
on ATP does not exhibit positive cooperativity. ET stands for the total concentration of enzymes. For 
this scheme, expressions for the overall velocity, kobs and KTapp, may be derived. 
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Equation 1: v =
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From the fit of the non-essential activator model with all of the kinetic data (Equation 1, Table 2), 
the ATPase activities were fitted reasonably well (Figure S1), similar to that of the Michaelis-Menten 
kinetics (Figure 2) with minor changes in the extrapolated Vmax (Figure S1). The goodness of fit in 
all three membrane conditions are also shown in Table S1. In addition, we were able to obtain the 
different kinetic parameters, kobs, KT, KS, a and b (Table 2). The observed turnover rates are 17.6 
min-1 in detergent, 23.3 min-1 in ND, and 9 min-1 in PLS (Table 2), similar to that in the Michaelis-
Menten kinetics in the absence of GSSG (Table 1a), and the observed binding affinities of MgATP 
are 0.82 mM in detergent, 1.41 mM in ND, and 1.6 mM in PLS, also close to those of the Michaelis-
Menten kinetics (Table 1b). Yet, this fitting resulted in KS, binding affinity of GSSG, to about 10 
mM in detergent, ND, and PLS, which is inconsistent with the previously published data of a binding 
affinity that’s less than 1 mM for GSSG to the transporter in detergent (Lee et al. 2014). Additionally, 
the a value in detergent was about 1, suggesting no cooperativity between the MgATP and GSSG 
binding. In comparison, the values of a are 10 in ND and 3 in PLS, suggestive of negative 
cooperativity between GSSG and MgATP binding. In all conditions, the acceleration factors b value 
are 8.3, 77, and 29 in detergent, ND, and PLS, respectively (Table 2).  
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When using the non-essential activator model to model the GSSG concentration dependence of 
the turnover rates by fitting the observed values of the turnover rates from Michaelis-Menten kinetics 
(Table 1a) at various GSSG concentration using Equation 2, we observed that non-essential activator 
model could well captured the dependence of the turnover rate, kobs on the GSSG concentration in 
detergent, ND, and PLS, which is also reflected in the R2 values (Figure 3b). But this model failed 
to capture the effect of the substrate activator GSSG on KT at low GSSG concentrations for the 
detergent and ND conditions (Figure 3c) when fitted using Equation 3, again reflected in the R2. 
 
Expanded non-essential activator kinetic model 
To address this deficiency, an expanded activator model was developed with two additional 
parameters (Figure 4a) to accommodate two GSSG binding sites as observed crystallographically 
(Lee et al. 2014). The first GSSG binding is hypothesized to stabilize the ET state responsible for 
the basal ATPase rate, while the second GSSG binding stabilizes a conformation with a different 
affinity for MgATP (interaction factor g) and a significantly higher ATPase activity. For g, the 
convention is similar to that of a, in which g < 1 or > 1 separately denotes positive and negative 
cooperativity. Like the non-essential activator model, the non-linear fit in expanded non-essential 
activator using Equation 4 was also able to recapitulate the hyperbolic curves (Figure S2) observed 
in the Michaelis-Mention kinetics (Figure 1, Table S1) with small changes in the extrapolated values 
of the maximum velocities in all three membrane conditions.  
 
Equation 4: v =
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This expanded non-essential activator model could not only capture the dependence of kobs on the 
GSSG concentration (Figure 4b, Equation 5), but it could also fit the KT dependence on GSSG 
concentration in detergent, ND and PLS (Figure 4c, Equation 6). Within the framework of the 
expanded activator model, the MgATP binding constants in different membrane conditions, KT, are 
all about to 1 mM, while the first GSSG binds to the transporter with refined KS1 of ~0.3 mM in 
detergent and ~0.1 mM in ND and PLS, and the second GSSG binding to the transporter with a KS2 
of  ~10 mM in detergent, ND and PLS (Table 3). In detergent, the a value is 0.76, suggestive of 
small positive cooperativity between the binding of MgATP and GSSG. In contrast, the a values are 
1.07 and 1.2 in ND and PLS, respectively, corresponding to little or slight negative cooperativity. In 
contrast to the a values, the g values are 0.8 in detergent, 11 in ND, and 3.1 in PLS, respectively. 
The g values in ND and PLS are suggestive of negative cooperativity in ND and PLS, but the effects 
of MgATP binding on the first and second GSSG binding are different. Further, the binding of GSSG 
stimulates the ATPase activities as reflected in the acceleration factor b of 8 in detergent, 79 in ND, 
and 27 in PLS.  
 
3.4 Discussion  
The effects of the transported substrate GSSG of the ATPase activity of NaAtm1 were measured 
under three different conditions: 1) purified in a detergent mixture composed of 0.05% n-dodecyl-
β-D-maltopyranoside (DDM) and 0.5% octaethylene glycol monododecyl ether (C12E8) used in the 
structural studies, 2) reconstituted into nanodiscs (ND) composed of the MSP1D1 and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC), and 3) reconstituted into proteoliposomes (PLS) 
composed of Escherichia coli polar lipid extract and 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC). For a given GSSG concentration, the dependence of the ATPase activity on ATP could be 
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modeled by a Michaelis-Menten (hyperbolic) equation, yielding the kcat and KM for ATP 
hydrolysis as a function of GSSG concentration (Table 1). In the absence of GSSG, the kcat 
characterizing the basal ATPase rate was 18.0 ± 0.4, 22.6 ± 0.5, and 9.5 ± 0.4 min-1 in detergent, ND 
and PLS, respectively. In each system, GSSG was observed to stimulate the ATPase activity of 
NaAtm1 in a concentration dependent fashion (Figure 2, Table 1), although the magnitude of the 
stimulation was dependent on the conditions; the kcat’s were increased above the basal rate by factors 
of ~5, 14, and 11, in detergent, ND and PLS, respectively. Less pronounced changes, but statistically 
significant changes in KM were also observed, corresponding to a decrease of ~20% in detergent, 
and increases of 2.7 and 1.9 times in ND and PLS, respectively.  
 
An important aspect of this analysis is the opportunity to explore the binding interactions between 
ATP and GSSG, which are reflected in the cooperativity parameters a and g. In detergent, little 
cooperativity is evident, with a ~ 1 for the basic model, and a and g ~ 0.8 for the expanded (suggests 
of slight positive cooperativity). In contrast, in ND and PLS, evidence for negative cooperativity is 
evident with a ~ 10 and 3 respectively in the basic model; comparable values are observed for g in 
the expanded model, with a ~1 for the binding of the first GSSG molecule. The acceleration factor 
b is significantly larger in ND and PLS (79 and 27, respectively), compared to b ~8 in detergent 
(Table 3). Reflecting large value of g observed in ND, however, the maximal activity in the presence 
of GSSG occurs at concentrations much higher than were used in this study (Fig 3b, 4b).   
 
While our previously determined structural models help define the ligand dependence of the NaAtm1 
conformational state, the kinetic models presented in this study define the ligand dependence of the 
ATPase activity. Integration of the structural and kinetic models remains challenging, however. An 
important open question concerns the conformational states of the various species in the kinetic 
models (Figures 3a and 4a). The structural studies are consistent with the free transporter and the 
transporter-GSSG complex (E and ES species, respectively) primarily adopting inward-facing 
conformations, while transporter-ATP states (ET) primarily exhibit occluded or outward-facing 
conformations. The preference for GSSG and ATP to stabilize distinct conformational states is 
consistent with the observed negative cooperativity in the binding of these ligands in ND and PLS 
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(although curiously, not in detergent). Of course, each kinetic state exists as a distribution of 
multiple states; for example, while ATP stabilizes outward-facing conformations, it must initially 
bind to the inward-facing conformation, and indeed ABC exporters complexed with ATP analogues 
have been observed in the inward-facing conformation (Shintre et al. 2013). The stimulation of the 
ATPase rate by GSSG requires that the transported ligand should stabilize NaAtm1 in the state 
competent for ATP hydrolysis. However, the structural studies of the individual ligands bound to the 
transporter suggest that ATP and GSSG preferentially bind to distinct conformations. Nevertheless, 
the ternary complex has an accelerated ATPase rate - understanding how this species promotes ATP 
hydrolysis is at the heart of the coupling mechanism and emphasizes the importance of characterizing 
the structure and dynamics of this elusive transporter-ATP-substrate state. 
 
3.5 Materials and Methods 
Protein expression, purification and reconstitution  
NaAtm1 was previously deposited in Addgene (plasmid # 78308). The over-expression of NaAtm1 
was carried with Escherichia coli BL21-gold (DE3) cells (Agilent Technologies) using ZYM-5052 
autoinduction media as described previously (Lee et al. 2014). Cells were harvested by centrifugation 
and stored at -80 ˚C until use.  
 
Protein purification was carried out as follows. Frozen cell pellets were resuspended in lysis buffer 
containing 100 mM NaCl, 20 mM Tris, pH 7.5, 40 mM imidazole, pH 7.5, 10 mM MgCl2, 0.5% 
(w/v) n-dodecyl-β-D-maltopyranoside (DDM) (Anatrace), and 0.5% (w/v) octaethylene glycol 
monododecyl ether (C12E8) (Anatrace) in the presence of lysozyme, DNase, and protease inhibitor 
tablet. Resuspended cells were solubilized by stirring for 3 hrs at 4 ˚C. The lysate was 
ultracentrifuged at ~113,000x g for 45 minutes at 4 ˚C to remove unlysed cells and cell debris. The 
supernatant was loaded onto a prewashed NiNTA column. NiNTA wash buffer contained 100 mM 
NaCl, 20 mM Tris, pH 7.5, 50 mM imidazole, pH 7.5, 0.05% DDM and 0.05% C12E8 and the 
elution buffer contained 350 mM imidazole instead. The eluted sample was then subjected to size 
exclusion chromatography using HiLoad 16/60 Superdex 200 (GE Healthcare) with buffer 
containing 100 mM NaCl, 20 mM Tris, pH 7.5, 0.05% DDM and 0.05% C12E8. Peak fractions were 
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collected and concentrated with Amicon Ultra 15 concentrator (Millipore) (MW 100 kDa cutoff) 
to ~20 mg/ml.  
 
NaAtm1 nanodiscs in membrane scaffolding protein was reconstituted in membrane scaffolding 
protein (MSP1D1) with 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC). MSP1D1 was 
purchased from Addgene (plasmid # 20061) and its expression and purification were carried out by 
following published protocol (Ritchie et al. 2009). The detailed experimental protocol is described 
in Chapter 2. NaAtm1 in proteoliposomes was prepared by reconstituting detergent purified NaAtm1 
into liposomes containing Escherichia coli polar lipid extract and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) by following published protocol (Geertsma et al. 2008). The detailed 
experimental procedures are described in Chapter 2. 
 
ATPase assay 
The ATPase activities were measured by the molybdate-based phosphate quantification method 
(Chifflet et al. 1988). All reactions were carried out at 37 °C in 250 µL scale. The reaction mixture 
contains a final NaAtm1 concentration of 0.05 mg/ml, various concentrations of MgATP, pH 7.5, 
various concentrations of GSSG, pH 7.5, and buffer (100 mM NaCl and 20 mM Tris, pH 7.5). For 
each reaction, 50 µL of reaction mixture was taken every 5 minutes for 4 times and subsequently 
mixed with 50 µL of 12% SDS, 100 µL of ascorbic acid/molybdate mix, and 150 µL of citric 
acid/arsenite/acetic acid solution before reading with Tecan plate reader at 850 nm. Reactions in 
detergent and proteoliposomes were done in sextuplicates and reactions in nanodiscs were done in 
triplicates. The measurements were plotted against time to obtain the ATPase activities. The final 
rates were fitted into Michaelis-Menten kinetics or the non-essential activator models in Prism 8.  
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3.6 Figures 
 
 
Figure 1. ATPase assay setups.  
Schematics showing the ATPase reactions with (a) NaAtm1 purified in detergent, (b) NaAtm1 
reconstituted in nanodiscs and (c) NaAtm1 reconstituted in proteoliposomes. 
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Figure 2. ATPase activities of NaAtm1 fitted to Michaelis-Menten kinetics.  
ATPase activities of NaAtm1 in (a) detergent (DDM/C12E8), (b) nanodiscs (ND), and (c) 
proteoliposomes (PLS) with stimulations by GSSG at various concentrations. ATPase activities of 
NaAtm1 in detergent and PLS were measured six times, and three times in ND, all with distinct 
samples. All of the extrapolated Vmax values are shown next to each GSSG concentration curve. 
Error bars represent the standard error of the mean for the replicates.  
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Figure 3. Non-essential activator model of NaAtm1 ATPase kinetics.  
(a) Expanded activator model for the ATPase activities of NaAtm1. (b) Michaelis-Menten constant, 
KT, of MgATP binding, and (c) apparent rate constant, kobs, of ATP hydrolysis fittings based on the 
expanded activator model for NaAtm1 in detergent, nanodiscs, and proteoliposomes, respectively. 
In these schemes, E = NaAtm1, T = MgATP, D = ADP, S = GSSG, KT = binding constant for 
MgATP, KS = binding constant for GSSG, k = rate constant for MgATP hydrolysis, a = interaction 
factor of how ATP binding influences GSSG binding and vice versa, and b = acceleration factor for 
ATP hydrolysis with bound GSSG. Corresponding R2 values from non-linear regressions are 
labeled. Error bars represent the calculated standard deviations.  
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Figure 4. Expanded non-essential activator model of NaAtm1 ATPase kinetics.  
(a) Expanded activator model for the ATPase activities of NaAtm1. (b) Michaelis-Menten constant, 
KT, of MgATP binding, and (c) apparent rate constant, kobs, of ATP hydrolysis fittings based on the 
expanded activator model for NaAtm1 in detergent, nanodiscs, and proteoliposomes, respectively. 
In these schemes, E = NaAtm1, T = MgATP, D = ADP, S = GSSG, KT = binding constant for 
MgATP, KS1 and K S2 = binding constants for the first and second molecules of GSSG, respectively, 
k = rate constant for MgATP hydrolysis, a = interaction factor of how ATP binding influences first 
GSSG binding and vice versa, b = acceleration factor for ATP hydrolysis with bound GSSG, and g 
= interaction factor of how ATP binding influences the binding of second GSSG binding and vice 
versa. Corresponding R2 values from non-linear regressions are labeled. Error bars represent the 
calculated standard deviations.  
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3.7 Tables 
 
Table 1. Calculated Michaelis-Menten parameters.  
(a) Apparent rate constants for ATP hydrolysis and (b) apparent binding affinity of MgATP at 
different concentration of GSSG. 
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Table 2. Kinetic parameters of the non-essential activator model.  
Parameters calculated with the expanded activator model shown in Figure 3 and S1 for the ATPase 
activities of NaAtm1 in detergent, nanodiscs, and proteoliposomes. 
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Table 3. Kinetic parameters of the expanded non-essential activator model. Parameters 
calculated with the expanded activator model shown in Figure 4 and S2 for the ATPase activities of 
NaAtm1 in detergent, nanodiscs, and proteoliposomes. 
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3.8 Supplemental Information 
 
 
Figure S1. ATPase activities of NaAtm1 fitted to non-essential activator model.  
ATPase activities of NaAtm1 in (a) detergent (DDM/C12E8), (b) nanodiscs, and (c) 
proteoliposomes (PLS) with stimulations by GSSG at various concentrations. ATPase activities of 
NaAtm1 in detergent and PLS were measured six times, and three times in ND, all with distinct 
samples. All of the extrapolated Vmax values are shown next to each GSSG concentration curve. 
Error bars represent the standard error of the mean for the replicates.  
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Figure S2. ATPase activities of NaAtm1 fitted to expanded non-essential activator model.  
ATPase activities of NaAtm1 in (a) detergent (DDM/C12E8), (b) nanodiscs, and (c) 
proteoliposomes (PLS) with stimulations by GSSG at various concentrations. ATPase activities of 
NaAtm1 in detergent and PLS were measured six times, and three times in ND, all with distinct 
samples. All of the extrapolated Vmax values are shown next to each GSSG concentration curve. 
Error bars represent the standard error of the mean for the replicates. 
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Table S1. Goodness of fit comparison. 
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C h a p t e r  4  
CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI 
TRANSCRIPTION TERMINATION FACTOR RHO 
This chapter is adapted from:  
Fan, C. and Rees, D.C. “Crystal structure of the Escherichia coli transcription termination factor 
Rho.” Submitted. 
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4.1 Abstract 
During the crystal structure analysis of an ATP-Binding Cassette (ABC) transporter overexpressed 
in Escherichia coli, we crystallized a contaminant protein. The identity of the contaminant was 
revealed by mass spectrometry to be the Escherichia coli transcription terminator factor Rho, whose 
structures had been previously determined in different conformational states. Although Rho was 
present at only ~1% of the target protein (a bacterial homolog of the eukaryotic ABC transporter of 
mitochondria (Atm1) from Novosphingobium aromaticivorans (NaAtm1)), it preferentially 
crystallized in space group C2 as thin plates that diffracted to 3.3 Å resolution. The structure of Rho 
in this crystal form exhibits a hexameric open-ring staircase conformation with bound ATP; this 
characteristic structure was also observed on electron microscopy grids of the NaAtm1 preparation. 
 
4.2 Introduction 
Among the challenges in the crystallography of membrane proteins are the typically low expression 
levels, which necessitate a significant degree of purification to separate the protein of interest from 
all other cellular proteins. This can consequently lead to inadvertent purification of contaminant 
proteins that might otherwise be at negligible levels when the target protein expresses at high levels. 
In unfortunate cases, these impurities may crystallize more readily than the target protein, leading to 
misplaced enthusiasm until the contaminant is recognized. As examples, the multi-drug efflux pump 
AcrB is a well-known crystallization contaminant in membrane protein preparations due to its 
relatively high expression levels during recombinant protein expressions with antibiotic selection, 
and its nonspecific binding to NiNTA columns (Veesler et al. 2008, Das et al. 2007). Bacterioferritin 
has also been crystallized as a contaminant in preparations of cytochrome cbb3 oxidase (Nam et al. 
2010). In addition, exogenous proteins such as DNase, lysozyme and various proteases used in the 
target protein purification have also been shown as crystallization contaminants (Niedzialkowska et 
al. 2016). Compilations facilitate the identification of crystals of contaminant proteins (Hungler et 
al. 2016, Simpkin et al. 2018), but crystallization of “novel” impurities is still a concern. In this work, 
we report the crystal structure of a previously unreported contaminating protein, the transcription 
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termination factor Rho from Escherichia coli, obtained during the structural analysis of a 
bacterial ATP-Binding Cassette (ABC) transporter. 
 
Rho is a hexameric RNA helicase that functions in transcription termination in Escherichia coli. The 
six subunits together form a ring-like structure, and the structure switches between an open-ring 
staircase conformation to a closed-ring conformation coupled to the binding and hydrolysis of ATP 
(Skordalakes and Berger 2003, Thomsen and Berger 2009). Here, we present the crystal structure of 
Rho in a broken staircase conformation at 3.30 Å resolution with ATP bound. 
 
4.3 Results and Discussion 
Crystals of Rho were unexpectedly obtained during studies of the bacterial ABC transporter NaAtm1 
from Novosphingobium aromaticivorans. NaAtm1 was recombinantly expressed in Escherichia coli 
BL21(DE3)-gold cells with a C-terminal 6xHis-tag following a previously established protocol (Lee 
et al. 2014). After solubilization of the Escherichia coli cells in n-dodecyl-β-D-maltopyranoside 
(DDM) and octaethylene glycol monododecyl ether (C12E8), the protein purification proceeded by 
NiNTA affinity purification followed by size exclusion chromatography (Figure 1a). SDS-PAGE 
gels indicated a high degree of purity, although in subsequent analysis of overloaded gels, a small 
amount of another protein was present at molecular weight of ~40 kDa (Figure 1b).  
 
Crystals obtained during a crystallization optimization were in space group C2 with cell dimensions: 
a = 161.8 Å, b = 101.9 Å, c = 184.0 Å, and b = 107.8˚. The asymmetric unit volume was of sufficient 
size to accommodate a NaAtm1 dimer (molecular weight 133 kDa). Analysis of the self-rotation 
function calculated from diffraction data revealed a non-crystallographic symmetry (NCS) 6-fold 
axis offset ~3-4˚ from the crystallographic a-axis. Interaction of the perpendicular 2-fold and 6-fold 
axes generates a set of non-crystallographic two-fold rotation operations separated by 60˚ in the 
plane perpendicular to the NCS 6-fold axis (Figure 1c). Given the unit cell dimensions, this apparent 
NCS was incompatible with dimeric NaAtm1, which raised the possibility that a contaminant was 
crystallized. With an estimated molecular weight of ~40 kDa based on the observation of a faint 
impurity band in SDS-PAGE and a Matthews coefficient analysis, we then performed molecular 
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replacements with the known crystallization contaminants (Hungler et al. 2016, Simpkin et al. 
2018), which all failed to yield a molecular replacement solution. 
 
Identification of Rho (molecular weight 47 kDa) was established by a mass spectrometry analysis of 
the peptides prepared by trypsin digestion of protein in the SDS-PAGE bands. With this information, 
we were able to obtain a molecular replacement solution using Rho in the AMPPNP bound state 
(PDB ID: 1PVO; (Skordalakes and Berger 2003)) as input model. The molecular replacement results 
established that in these crystals, Rho adopts a six-membered broken staircase conformation. The 
structure was refined to Rwork and Rfree of 25.2% and 29.6%, respectively (Table 4). The electron 
density map also revealed ATP bound at all six subunits (Figure 2a). The individual Rho subunits 
are structurally similar overall, except for the terminal subunit at the “break” in the staircase, where 
the first 50 residues at the N-terminus exhibited a shift of 2 to 8 Å relative to the other monomers 
(Figure 2b). The overall RMSD between the present structure and the molecular replacement input 
model (PDB ID: 1PVO) is 2.5 Å, with the present structure exhibiting a more closed ring in 
comparison to the original broken staircase structure (Figure 3ab).  
 
How did Rho end up in our crystallization conditions? Our hypothesis is that during protein 
overexpression, the Escherichia coli transcription and translation machineries are highly expressed 
for the production of mRNAs and recombinant proteins, respectively. Rho, as the termination factor, 
would plausibly be overexpressed as part of the transcription termination process. The fact that Rho 
eluted from the NiNTA column along with His-tagged NaAtm1 suggests that there is nonspecific 
binding to the Ni2+ resin by the histidine residues distributed throughout the whole protein (Figure 
3c). The open ring conformation that Rho adopts in solution (Thomsen et al. 2016) with a molecular 
weight of 282 kDa for the hexamer apparently has a comparable hydrodynamic radius to 
NaAtm1with a dimer molecular weight of 133 kDa in addition to the detergent micelle. Given the 
low abundance, the presence of Rho in the SEC fractions was only detected in hindsight. 
 
We have also observed Rho in single particle cryoEM studies of NaAtm1 reconstituted in membrane 
scaffolding protein (MSP) nanodiscs. The NaAtm1 nanodiscs sample was prepared by incubating 
detergent purified NaAtm1 with MSPs and lipids, and further purified by size exclusion 
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chromatography. Similar to the purification in detergent, the peak fractions were collected for 
single particle cryo-EM sample preparation (Figure 4a). The 2D classification reported one class of 
Rho in the broken hexameric state (Figure 4b), again suggesting that Rho has a similar hydrodynamic 
radius and plausibly similar molecular weight to our reconstituted NaAtm1 in nanodiscs. 
 
In a structural analysis of a prokaryotic chloride channel, a single peptide of Rho was identified in a 
mass spectrometry analysis of the gel band (Abeyrathne and Grigorieff 2017), representing for the 
first time, to our knowledge, that Rho was identified as a possible contaminant during membrane 
protein expression. As demonstrated in this report, Rho can crystallize even in the presence of a large 
excess of other proteins, and thus it should be added to the list of the known crystallography 
contaminant proteins. 
 
4.4 Materials and Methods 
Protein expression and purification 
Rho co-purified with the bacterial ABC exporter NaAtm1, a homolog of the ABC transporter of 
mitochondria (Atm1) from Novosphingobium aromaticivorans, using an Escherichia coli expression 
system and a modified version of previously published protocols (Lee et al. 2014). Briefly, frozen 
Escherichia coli cell pellets containing overexpressed NaAtm1 (and Rho) were lysed in lysis buffer 
containing 100 mM NaCl, 20 mM Tris, pH 7.5, 40 mM imidazole, pH 7.5, 10 mM MgCl2, 0.5% 
(w/v) n-dodecyl-β-D-maltopyranoside (DDM) (Anatrace), 0.5% (w/v) octaethylene glycol 
monododecyl ether (C12E8) (Anatrace) with the addition of lysozyme, DNase, and protease 
inhibitor. After stirring for 3 hours at 4 ˚C, the lysate was subjected to ultracentrifugation at 
~113,000x g for 45 minutes at 4 ˚C. The supernatant was collected and loaded onto a pre-washed 
NiNTA column in buffer containing 100 mM NaCl, 20 mM Tris, pH 7.5, 50 mM imidazole, pH 7.5, 
0.05% DDM and 0.05% C12E8 and eluted with the same buffer containing 350 mM imidazole, pH 
7.5. The protein was further purified by size exclusion chromatography (SEC) using a HiLoad 16/60 
Superdex 200 column (GE Healthcare) with SEC buffer containing 100 mM NaCl, 20 mM Tris, pH 
7.5, 0.05% DDM and 0.05% C12E8. Peak fractions were collected and concentrated to ~20 mg/mL 
using a 100 kDa cutoff Amicon Ultra 15 concentrator (Millipore). 
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Crystallization  
Rho crystallized during the crystallization trials of NaAtm1 under the optimized conditions of 
MemGold (Molecular Dimensions) condition #68 at 20 ˚C. The final crystallization condition 
contains 100 mM NaCl, 100 mM Tris, pH 8.3, and 28% polyethylene glycol 2,000 monomethyl 
ether (PEG 2,000 MME), 0.2 M non-detergent sulfo-betaine (NDSB)-221 and 20 mM ATP, pH 7.5. 
The crystallization sample was prepared with 1 mM ATP, pH 7.5 and 5 mM EDTA, pH 7.5 in the 
presence and absence of 5 mM oxidized glutathione (GSSG), pH 7.5, a transport ligand for NaAtm1. 
Thin plate crystals appeared in about 2 weeks. Crystals were harvested in cryoprotectant solutions 
containing 100 mM NaCl, 100 mM Tris, pH 8.3, 28% PEG 2,000 MME with PEG 400 at 10%, 15%, 
and 20% before flash-freezing in liquid nitrogen. 
 
Data collection and processing  
Crystals were screened at the Advanced Photon Source GM/CA beamline 23ID-B and the Stanford 
Synchrotron Radiation Laboratory beamline 12-2. The final dataset was collected at the GM/CA 
beamline 23-IDB with an Eiger 16M detector (Dectris) with JBluIce-EPICS (Stepanov et al. 2011), 
processed and integrated with XDS (Kabsch 2010), and scaled with Aimless (Evans and Murshudov 
2013). The crystals of Rho diffracted to about 3.30 Å resolution in space group C2 with unit cell 
constants: a = 161.8 Å, b =101.9 Å, c =184.0 Å, and b =107.8°. 
 
Structure solution and refinement  
The self-rotation function was calculated with the CCP4 program molrep (Winn et al. 2011). 
Molecular replacement was performed with Phaser in Phenix (Adams et al. 2010) using a monomeric 
subunit of a previous structure of Rho with PDB ID: 1PVO. Initial jelly-body refinements were 
carried out with Refmac5 in CCP4 (Winn et al. 2011). Subsequent iterative refinement and model 
building runs were separately conducted with phenix.refine (Adams et al. 2010) and Coot (Emsley 
et al. 2010).  
 
Electron microscopy sample preparation 
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The expression plasmid for the membrane scaffolding protein MSP1D1 was purchased from 
Addgene (plasmid #20061). The expression and purification of MSP1D1 were carried out using 
published protocols with minor modifications (Ritchie et al. 2009). Reconstitution of NaAtm1 (and 
the Rho contaminant) with MSP1D1 was carried out with 1-palmitoyl-2-oleoyl-glycero-3-
phosphocholine (POPC) at a molar ratio of NaAtm1: MSP1D1: POPC = 1:2:130. This reconstituted 
sample was incubated overnight at 4˚C. BioBeads were added after two hours of incubation at 200 
mg/ml for detergent removal. The sample was then subjected to size exclusion chromatography with 
Superdex 200 Increase 10/300 (GE Healthcare). The peak fractions were then pooled and 
concentrated to ~8 mg/ml. 
 
EM grids were prepared with a protein concentration of 4 mg/ml in the presence of 5 mM GSSG 
and 5 mM AMPPNP. 3 µl of protein sample was applied to freshly glow discharged QuantiFoil Cu 
R2/2 300 mesh grids and blotted for 4 seconds with blot force of 0 and 100% humidity at room 
temperature using Vitrobot MarkIV (FEI). The data was collected on a 200 keV Talos Arctica with 
a Falcon III detector at a magnification of 92,000x and a total dosage of 81 e-/Å2 at the Caltech 
CryoEM Facility.  
 
The data processing was performed with cryoSPARC 2 (Punjani et al. 2017), following motion 
corrected with full-frame motion, and estimation of the contrast transfer function (CTF) with 
CTFFIND (Rohou and Grigorieff 2015). Particles were picked using a reconstruction of NaAtm1 as 
template and extracted in cryoSPARC 2. The initial 2D classification revealed a single class of Rho 
with ~2,500 particles. The particles were then 2D-classed again into five classes with four good 
classes with a total of ~2,200 particles shown in Figure 4b. 
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4.6 Figures 
 
 
Figure 1. Purification and self-rotation function analysis of Rho.  
(a) Size exclusion chromatograph of NaAtm1 purification using a HiLoad Superdex 200 16/60 
column. (b) SDS-PAGE of the peak fractions of SEC purification from (a). (c) The Chi = 180˚ and 
60˚ sections of the self-rotation function calculated using molrep in CCP4 with an integration radius 
of 51 Å using diffraction data between 3.3 to 40 Å resolution.  
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Figure 2. Crystal structure of Rho.  
(a) Overall view of Rho in broken staircase conformation with ATP bound. (b) Single subunit of 
Rho with ATP bound. The six subunits are shown separately, and ATP is shown in red spheres. The 
dashed circle identifies the N-terminal ~50 residues of the Rho subunit positioned at the break in the 
hexameric staircase arrangement; this region has rearranged in this subunit relative to the 
conformation exhibited in the other five subunits. 
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Figure 3. Overall architecture of Rho. 
Overall structural representations of (a) ATP bound Rho (this study) and (b) AMPPNP bound 
structure of Rho (PDB ID: 1PVO; (Skordalakes and Berger 2003)). (c) Distribution of surface 
histidine residues (colored by residue number) in the ATP bound structure of Rho. The spacings 
between the surface exposed histidines are several nanometers, comparable to the loading density of 
His-tagged proteins bound to NiNTA beads (Hayworth and Hermanson 2014), which presumably 
allows multiple binding sites to NiNTA and contributes to the observed affinity of Rho for NiNTA 
resin. 
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Figure 4. Single particle cryo-EM analysis of NaAtm1 samples containing Rho.  
(a) Size exclusion chromatograph of the reconstituted NaAtm1 in MSP1D1 nanodiscs using 
Superdex 200 Increase 10/300. (b) 2D classes of Rho illustrating the hexameric arrangement with a 
diameter of ~100 Å. 
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4.7 Tables 
Table 1. Macromolecule production information.  
Source organism Escherichia coli 
DNA source Escherichia coli genomic DNA 
Expression host Escherichia coli BL21-gold (DE3) 
Complete amino acid 
sequence of the construct 
produced 
MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGV
LEILQDGFGFLRSADSSYLAGPDDIYVSPSQIRRFNLRTGDTISGKIRPPKEGE
RYFALLKVNEVNFDKPENARNKILFENLTPLHANSRLRMERGNGSTEDLTARVL
DLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHPDCVLMVLLIDERPEEV
TEMQRLVKGEVVASTFDEPASRHVQVAEMVIEKAKRLVEHKKDVIILLDSITRL
ARAYNTVVPASGKVLTGGVDANALHRPKRFFGAARNVEEGGSLTIIATALIDTG
SKMDEVIYEEFKGTGNMELHLSRKIAEKRVFPAIDYNRSGTRKEELLTTQEELQ
KMWILRKIIHPMGEIDAMEFLINKLAMTKTNDDFFEMMKRS  
The protein was expressed in Escherichia coli without the use of an expression plasmid. 
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Table 2. Crystallization. 
Method Vapor diffusion 
Plate type Hampton VDX 
Temperature (K) 293 K 
Protein concentration < 1 mg/ml 
Buffer composition of protein solution 100 mM NaCl, 20 mM Tris, pH 7.5 
Composition of reservoir solution 100 mM NaCl, 100 mM Tris, pH 8.3, 20 mM ATP, 
200 mM NDSB 221, and 28% PEG 2,000 MME   
Volume and ratio of drop 1 µl protein solution + 1 µl reservoir solution  
Volume of reservoir 500 µL 
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Table 3. Data collection and processing. 
Values for the outer shell are given in parentheses.  
Diffraction source APS GM/CA 23ID-B 
Wavelength (Å) 0.9793 
Temperature (K) 100  
Detector DECTRIS EIGER 16M 
Crystal-detector distance (mm) 400 
Rotation range per image (°) 0.2 
Total rotation range (°) 360 
Exposure time per image (s) 0.2 
Space group C2 
a, b, c (Å)  161.74, 101.90, 184.02 
α, β, γ (°)  90, 107.8, 90 
Mosaicity (°)  0.11 
Resolution range (Å) 38.51 - 3.30 (3.42 - 3.30)  
Total no. of reflections 304,610 (29,798) 
No. of unique reflections 43,031 (4,465) 
Completeness (%) 99.9 (99.7) 
Redundancy 7.0 (6.7) 
〈 I/σ(I)〉  6.6 (1.5) # 
Rpim  0.103 (0.729) 
Overall B factor from Wilson plot (Å2)  79.1 ‡ 
# Overall resolution cut-off determined by data completeness and CC1/2 > 0.50 in high resolution shell.  I/σ(I) falls 
below 2.0 past 3.46 Å resolution.  
‡ There were ice rings in the data.  
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Table 4. Structure solution and refinement  
Values for the outer shell are given in parentheses.  
Resolution range (Å) 38.51 - 3.30 (3.42 - 3.30) 
Completeness (%) 99.6 (97.3) 
σ cutoff  8.9 (1.3) 
No. of reflections, working set 42,901 (4,145) 
No. of reflections, test set 2,095 (217) 
Final Rcryst  0.252 (0.320) 
Final Rfree  0.296 (0.364) 
No. of non-H atoms 19,776 
   Protein 19,590 
   Ligand  186 
   Total 19,776 
R.m.s. deviations    
   Bonds (Å) 0.002 
   Angles (°) 0.58 
Average B factors (Å2)    
   Protein 101.4 
   Ligand  143.2 
Ramachandran plot    
 Most favored (%) 95.5 
 Allowed (%) 4.2 
  
 
 
133 
4.8 References 
Abeyrathne, P. D., and N. Grigorieff. 2017. “Expression, purification, and contaminant detection 
for structural studies of Ralstonia metallidurance ClC protein rm1.”  PLoS One 12 
(7):e0180163. doi: 10.1371/journal.pone.0180163. 
Adams, P. D., P. V. Afonine, G. Bunkoczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L. 
W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. 
Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, and P. H. 
Zwart. 2010. “PHENIX: A comprehensive Python-based system for macromolecular 
structure solution.”  Acta Crystallographica D Biological Crystallography 66 (Pt 2):213-
21. doi: 10.1107/S0907444909052925. 
Das, D., Q. S. Xu, J. Y. Lee, I. Ankoudinova, C. Huang, Y. Lou, A. DeGiovanni, R. Kim, and S. 
H. Kim. 2007. “Crystal structure of the multidrug efflux transporter AcrB at 3.1Å 
resolution reveals the N-terminal region with conserved amino acids.”  Journal of 
Structural Biology 158 (3):494-502. doi: 10.1016/j.jsb.2006.12.004. 
Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2010. “Features and development of 
Coot.”  Acta Crystallographica D Biological Crystallography 66 (Pt 4):486-501. doi: 
10.1107/S0907444910007493. 
Evans, P. R., and G. N. Murshudov. 2013. “How good are my data and what is the resolution?”  
Acta Crystallographica D Biological Crystallography 69 (Pt 7):1204-14. doi: 
10.1107/S0907444913000061. 
Hayworth, Douglas A. , and Greg T.  Hermanson. 2014. “Calculate the number of immobilized 
proteins per bead of agarose affinity supports.” accessed April 5. 
https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-
learning-center/protein-biology-resource-library/protein-biology-application-
notes/calculate-number-immobilized-proteins-per-bead-agarose-affinity-supports.html. 
Hungler, A., A. Momin, K. Diederichs, and S. T. Arold. 2016. “ContaMiner and ContaBase: A 
webserver and database for early identification of unwantedly crystallized protein 
contaminants.”  Journal of Applied Crystallography 49 (Pt 6):2252-2258. doi: 
10.1107/S1600576716014965. 
 
 
134 
Kabsch, W. 2010. “Xds.”  Acta Crystallographica D Biological Crystallography 66 (Pt 
2):125-32. doi: 10.1107/S0907444909047337. 
Lee, J. Y., J. G. Yang, D. Zhitnitsky, O. Lewinson, and D. C. Rees. 2014. “Structural basis for 
heavy metal detoxification by an Atm1-type ABC exporter.”  Science 343 (6175):1133-6. 
doi: 10.1126/science.1246489. 
Nam, K. H., Y. Xu, S. Piao, A. Priyadarshi, E. H. Lee, H. Y. Kim, Y. H. Jeon, N. C. Ha, and K. 
Y. Hwang. 2010. “Crystal structure of bacterioferritin from Rhodobacter sphaeroides.”  
Biochemical and Biophysical Research Communications 391 (1):990-4. doi: 
10.1016/j.bbrc.2009.12.003. 
Niedzialkowska, E., O. Gasiorowska, K. B. Handing, K. A. Majorek, P. J. Porebski, I. G. 
Shabalin, E. Zasadzinska, M. Cymborowski, and W. Minor. 2016. “Protein purification 
and crystallization artifacts: The tale usually not told.”  Protein Science 25 (3):720-33. 
doi: 10.1002/pro.2861. 
Punjani, A., J. L. Rubinstein, D. J. Fleet, and M. A. Brubaker. 2017. “cryoSPARC: Algorithms 
for rapid unsupervised cryo-EM structure determination.”  Nature Methods 14 (3):290-
296. doi: 10.1038/nmeth.4169. 
Ritchie, T. K., Y. V. Grinkova, T. H. Bayburt, I. G. Denisov, J. K. Zolnerciks, W. M. Atkins, and 
S. G. Sligar. 2009. “Reconstitution of membrane proteins in phospholipid bilayer 
nanodiscs.” In Methods in Enzymology, 211-231. 
Rohou, A., and N. Grigorieff. 2015. “CTFFIND4: Fast and accurate defocus estimation from 
electron micrographs.”  Journal of Structural Biology 192 (2):216-21. doi: 
10.1016/j.jsb.2015.08.008. 
Simpkin, A. J., F. Simkovic, J. M. H. Thomas, M. Savko, A. Lebedev, V. Uski, C. Ballard, M. 
Wojdyr, R. Wu, R. Sanishvili, Y. Xu, M. N. Lisa, A. Buschiazzo, W. Shepard, D. J. 
Rigden, and R. M. Keegan. 2018. “SIMBAD: A sequence-independent molecular-
replacement pipeline.”  Acta Crystallographica D Structural Biology 74 (Pt 7):595-605. 
doi: 10.1107/S2059798318005752. 
Skordalakes, Emmanuel, and James M. Berger. 2003. “Structure of the Rho transcription 
terminator.”  Cell 114 (1):135-146. doi: 10.1016/s0092-8674(03)00512-9. 
 
 
135 
Stepanov, S., O. Makarov, M. Hilgart, S. B. Pothineni, A. Urakhchin, S. Devarapalli, D. 
Yoder, M. Becker, C. Ogata, R. Sanishvili, N. Venugopalan, J. L. Smith, and R. F. 
Fischetti. 2011. “JBluIce-EPICS control system for macromolecular crystallography.”  
Acta Crystallographica D Biological Crystallography 67 (Pt 3):176-88. doi: 
10.1107/S0907444910053916. 
Thomsen, N. D., and J. M. Berger. 2009. “Running in reverse: The structural basis for 
translocation polarity in hexameric helicases.”  Cell 139 (3):523-34. doi: 
10.1016/j.cell.2009.08.043. 
Thomsen, N. D., M. R. Lawson, L. B. Witkowsky, S. Qu, and J. M. Berger. 2016. “Molecular 
mechanisms of substrate-controlled ring dynamics and substepping in a nucleic acid-
dependent hexameric motor.”  Proceedings of the National Academy of Sciences of the 
United States of America 113 (48):E7691-E7700. doi: 10.1073/pnas.1616745113. 
Veesler, D., S. Blangy, C. Cambillau, and G. Sciara. 2008. “There is a baby in the bath water: 
AcrB contamination is a major problem in membrane-protein crystallization.”  Acta 
Crystallographica F Structural Biology and Crystallization Communications 64 (Pt 
10):880-5. doi: 10.1107/S1744309108028248. 
Winn, M. D., C. C. Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R. Evans, R. M. Keegan, 
E. B. Krissinel, A. G. Leslie, A. McCoy, S. J. McNicholas, G. N. Murshudov, N. S. 
Pannu, E. A. Potterton, H. R. Powell, R. J. Read, A. Vagin, and K. S. Wilson. 2011. 
“Overview of the CCP4 suite and current developments.”  Acta Crystallographica D 
Biological Crystallography 67 (Pt 4):235-42. doi: 10.1107/S0907444910045749. 
 
 
136 
C h a p t e r  5  
STRUCTURAL ANALYSIS OF PERIPLASMIC BINDING PROTEIN-
DERIVED BIOSENSORS 
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iDrugSnFRs, nearly modular fusion of evolved periplasmic binding proteins and circularly 
permutated GFP for subcellular and supercellular dynamical measurements of drugs.” In 
preparation. 
Borden, P.M., Zhang, P., Shivange, A.V., Marvin, J.S., Cichon, J., Dan, C., Podgorski, K., 
Figueiredo, A., Novak, O., Tanimoto, M., Shigetomi, E., Lobas, M.A., Kim, H.,  Zhu, P.K., 
Zhang, Y., Zheng, W.S., Fan, C., Wang, G., Xiang, B., Gan, L., Zhang, G., Guo, K., Lin, L., 
Cai, Y., Yee, A.G, Aggarwal, A., Ford, C.P., Rees, D.C., Dietrich, D, Khakh, B.S., Dittman, 
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L.L. “A fast genetically encoded fluorescent sensor for faithful in vivo acetylcholine detection 
in mice, fish, worms, and flies.” In review. 
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5.1 Introduction 
There has been significant interest in probing the intracellular concentrations of neurotransmitters 
over the past decade. One of the first genetically engineered biosensors for this purpose was a Ca2+ 
sensitive probe based on calmodulin and green fluorescent protein (GFP), named G-CaMP. G-CaMP 
could sense Ca2+ concentration in the nanomolar range with large fluorescence changes (Yamaguchi 
et al. 2001). G-CaMP was designed by genetically engineering a fusion protein of a circular 
permutated enhanced green fluorescent protein (cpEGFP), a Ca2+ binding calmodulin (CaM), and a 
M13 peptide from myosin light chain kinase (Nakai, Ohkura, and Imoto 2001). The same general 
strategy was later adopted in designing biosensors for maltose (Marvin et al. 2011), neurotransmitters 
(Marvin et al. 2013, Marvin et al. 2018), and smoking sensation drugs (Shivange et al. 2019). The 
basic design of these subsequent biosensors employed a periplasmic binding protein (PBP) from a 
bacterial ATP-Binding Cassette (ABC) transporter system and a circular-permutated green 
fluorescent protein (cpGFP). The cpGFP moiety is inserted between the N and C-terminal lobes of 
the PBP via two separate linkers. These linkers are thought to be important in sensing the apo and 
liganded conformational states of the PBP. Upon ligand binding to apo PBP, conformational changes 
of the linkers promote the last folding step of the cpGFP, resulting in a fluorescence increase.  
 
The Lester group has pioneered the development of a family of genetically encoded nicotine sensing 
fluorescent reporters, known as the iNicSnFRs, and a family of the genetically encoded acetylcholine 
sensing fluorescent reporters, known as the iAChSnFRs. These two families were designed from the 
same bacterial PBP, through modification and evolution of the protein sequence to optimize ligand 
binding affinity, ligand binding specificity, fluorescent effective range, and pH sensitivity. Following 
the initial screening of acetylcholine and choline binding proteins from different organisms, the PBP 
used in designing the iNicSnFRs and iAChSnFRs is the betaine/choline-binding protein OpuBC 
from Thermoanaerobacter sp. X513 (Shivange et al. 2019, Borden et al. 2020). These OpuBC based 
biosensors are designed like the early PBP based biosensors with the cpGFP inserted in the middle 
of the PBP via two linkers (Figure 1a). In addition, epitope tags were also included, with an HA-tag 
on the N-terminus and a MYC-tag on the C-terminus of the biosensor. For purification purposes, a 
6xHis tag is placed on the N-terminus of the fusion protein before the HA-tag (Figure 1a). Currently, 
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iNicSnFRs have apparent binding affinities of  ~10 µM for nicotine (Shivange et al. 2019), and 
iAChSnFRs has apparent binding affinity of ~1 µM for acetylcholine (Borden et al. 2020). Missing 
from the characterization of these biosensors has been direct structural characterization of the 
liganded states, which is necessary for understanding the specificity of ligand binding. Here, we have 
determined high X-ray structures of iNicSnFRs and iAChSnFRs in both the apo and liganded states. 
 
5.2 Results 
Crystallization construct design 
Initial crystallization studies were carried out with full length iNicSnFR3 with about 20 different 
commercial crystallization screens in the presence of 10 mM nicotine, pH 7.5. Unfortunately, none 
of the crystal hits yielded any structures with nicotine bound, albeit they all diffracted to the 2 to 3 
Å resolution range without any optimization. To improve the crystallizability of the biosensors in 
the liganded states, we removed the potentially floppy HA and MYC epitope tags for crystallization 
purposes; these constructs are referred to as “dt” constructs where dt stands for D (delta) tags (Figure 
1b). Furthermore, to help crystallization and determination of high-resolution structures, we removed 
the cpGFP and the linkers of iNicSnFR3dt and other dt constructs, leaving only the His-tagged PBP 
of the biosensors (Figure 1c). These cpGFP-less constructs are referred as the “dtbp” constructs 
where dtbp stands for delta binding protein. This strategy is applied for all the biosensor structures 
discussed in this Chapter, including the iNicSnFR3, iNicSnFR4, and iAChSnFR. 
 
Crystal structures of the nicotine and varenicline bound iNicSnFR3dt 
Crystals of iNicSnFR3dt in the presence of 10 mM nicotine diffracted to 2.95 Å resolution in space 
group P61 with unit cell constants: a = b = 192.3 Å, c = 49.7 Å, a = b = 90°, and g = 120°. Overall, 
the PBP domain of iNicSnFR3dt adopts a closed conformation (Figure 2a). In the binding pocket 
between the top and bottom lobes of the PBP (Figure 2a), we have observed an “avocado” shaped 
electron density in the nicotine binding site. This density blob is enclosed by a number of different 
aromatic residues, including phenylalanine, tyrosine and tryptophan (Figure 2b). Further map 
calculation using polder map in Phenix (Adams et al. 2010) suggested the presence of nicotine in the 
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binding pocket between the two lobes. Based on the molecular geometry of nicotine, the distorted 
pyrrolidine should be placed on the electron-heavier side of the electron density blob and the flat 
pyridine ring should be placed on the thinner side of the electron density blob. Yet, nicotine could 
adopt both cis and trans conformations in response to deprotonation and protonation of the nitrogen 
in the pyrrolidine ring and the pyridine ring is also associated with rotation (Figure 2c) (Elmore and 
Dougherty 2000). These conformational dynamics of nicotine make it difficult to unambiguously 
place it in the binding pocket.  
 
To obtain a liganded biosensor structure, we tried different ligands and were successful in 
crystallizing iNicSnFR3dt in the presence of 10 mM varenicline in the same crystallization 
condition. Varenicline is a smoking cessation drug used to treat nicotine addiction. Crystals of 
iNicSnFR3dt with varenicline bound were isomorphous to those of the nicotine bound crystals and 
diffracted to 3.2 Å resolution. While the protein structure (Figure 3a) is identical to that of the 
nicotine bound structure (Figure 2a), we were able to unambiguously place varenicline in the same 
binding pocket. Similar to the avocado blob observed in the nicotine bound structure, varenicline is 
also enclosed by the same aromatic residues, forming an extensive amount of hydrophobic 
interactions with the pocket residues (Figure 3b). 
 
Crystal structures of the apo iNicSnFR3dt 
iNicSnFR3dt also crystallized in the apo state in space group P1, diffracting to 2.5 Å resolution with 
unit cell constants of a = 81.2 Å, b = 86.0 Å, c = 91.8 Å, a = 75.7°, b = 85.6°, and g = 85.3°. Although 
there are four copies of iNicSnFR3dt in the asymmetric unit, they all share the same overall open 
conformation (Figure 4a). In comparison to the varenicline bound structure, this open conformation 
has the two lobes of the PBP separated from each other (Figure 4a). Structural alignment based on 
the N-terminal 70 residues revealed the main conformational difference of the open and closed states 
is the hinge-bending motion of the PBP about the hinge helix connecting the two lobes. This 
conformational change is also referred to as the Venus-flytrap mechanism (Figure 4b). In addition, 
there’s a slight rotation of the cpGFP about the linker region between the two conformational states 
(Figure 4b). 
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The chromophore CRO in cpGFP moiety of the biosensors is formed by three consecutive 
residues, threonine, tyrosine and glycine. The resulting p-resonance systems accounts for the 
absorbance of GFP (Tsien 1998, Ormo et al. 1996). The fluorescence of the chromophore is known 
to be highly dependent on the surrounding water molecules and side chains (Brejc et al. 1997, Tsien 
1998). In understanding the conformation associated fluorescence changes, we’ve observed that a 
glutamate residue (E78) from the linker 1 region changes its orientation in which it interacts with 
two positively charged residues (K97 and R99) on the surface of the cpGFP in the liganded state, 
and this same glutamate residue forms a hydrogen bonding interaction with the chromophore of 
cpGFP in the unliganded apo state of iNicSnFR3dt. Presumably the liganded state of iNicSnFR3dt 
allows for a water molecule to hydrogen bond with the hydroxy group of the chromophore, 
promoting its fluorescence, but this water molecule was replaced by E78 in the unliganded state, 
which leads to the dark state of cpGFP.  
 
Crystal structures of the PBP domains of iNicSnFR and iAChSnFR 
By eliminating both the epitope tags and cpGFP, we were able to crystallize the PBP domains to 
high resolution. iNicSnFR3dtbp crystals diffracted to 1.1 Å resolution in an open conformation 
without substrate present (Figure 5a). In this structure, we observed a peptide bound in the binding 
pocket; after rounds of refinement, the identity of this peptide was revealed to be the N-terminal His-
tag with MHHH sequence bound such that with one histidine residue was inserted in between a 
tyrosine and a tryptophan residue. This observation suggests to us that these designed hydrophobic 
pockets for nicotine or other smoking cessation drugs also favor molecules with rings for binding. 
In addition, the binding protein domain of the iNicSnFR4, named as iNicSnFR4dtbp, was 
crystallized in both the apo and ligand states (Figure 5bc). The iNicSnFR4dtbp apo structure solved 
at 1.4 Å resolution (Figure 5b) with overall structure similar to that of the iNicSnFR3dtbp (Figure 
5a), sharing an overall RMSD of 0.4 Å. The structure of the varenicline bound iNicSnFR4dtbp was 
solved at 1.7 Å resolution (Figure 5c); it is also structurally similar to that of the iNicSnFR3dt PBP 
domain with an overall RMSD of 0.5Å (Figure 3). 
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Besides the iNicSnFRs, iAChSnFRdtbp also crystallized in liganded and apo states (Figure 5def). 
The first structure was of choline bound iAChSnFRdtbp at 1.55 Å resolution (Figure 5d). Choline 
was not used in the crystallization, instead the initial crystallization condition contained 10 mM 
acetylcholine. The presence of choline was presumably due to the hydrolysis of acetylcholine during 
the crystallization. We thus closely monitored the crystallization conditions to shorten the 
crystallization period to obtain acetylcholine bound iAChSnFRdtbp crystals, diffracting to 1.65 Å 
resolution (Figure 5e). These two liganded structures of iAChSnFRdtbp are structurally similar with 
an overall RMSD of 0.1 Å. Furthermore, the apo structure of iAChSnFRdtbp solved at 1.4 Å 
resolution is similar to the apo structures of iNicSnFR3dtbp and iNicSnFR4dtbp with overall 
RMSDs of 0.2 - 0.3 Å. 
 
Overall structural comparison 
Despite the different ligands, the binding protein domains of the liganded conformations of 
iNicSnFRs and iAChSnFR are structurally similar, and their corresponding ligands all bind in the 
binding pocket between the two PBP lobes as seen in the overall structural alignment (Figure 6a). 
Similarly, the open conformations of the “dtbp” constructs are also structurally similar to the open 
conformation of the binding protein domain of the iNicSnFR3dt (Figure 6b). This is suggestive that 
the removal of the cpGFP in the “dtbp” constructs does not alter the liganded and unliganded 
conformation of the PBP domain of the biosensors. 
 
In the binding pockets of the liganded structures for iNicSnFR3dt, iNicSnFR4dtbp, and 
iAChSnFRdtbp, the ligands, varenicline and acetylcholine are enclosed by the same set of residues 
(Figure 7). In the varenicline bound structure of iNicSnFR3dt (Figure 7a), varenicline forms cation-
p interactions with two of the tyrosine residues (Y65 and Y357) in the binding pocket and a 
secondary amine of varenicline forms a hydrogen bonding interaction with the carbonyl group of 
asparagine (N355) with a distance of 3.2 Å (Figure 7a). The same kind of cation-p and hydrogen 
bonding interaction are also observed in the iNicSnFR4dtbp varenicline bound structure with 
residues Y65, Y111, and N209 (Figure 7b). The residues numbers in the dtbp constructs are offset 
by a residue count of 246 after residue 78 in comparison to the full length and the “dt” construct due 
to the removal of the two linkers and the cpGFP moiety. The interacting residues are slightly different 
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in the acetylcholine bound iAChSnFRdtbp structure, where acetylcholine forms only cation- p 
interactions with the nearby tyrosine residues, Y65, Y111, and Y214 (Figure 7c). This is suggestive 
that there might be different binding interactions with different ligands. 
 
5.3 Discussion 
As these biosensors are all modified from the Thermoanaerobacter sp. X513 choline/betaine binding 
protein, one question is whether the design process for different ligands has affected the actual 
conformational changes between the open and closed conformation. We thus performed principal 
component analysis to characterize the major conformational changes. This analysis demonstrated 
that component 1 accounts for 75% of the total conformational change, which is associated with the 
hinge motion. Component 2 accounts for 17% of the total conformational change, which is 
associated with the overall conformational difference between the PBPs of biosensors and the other 
published betaine and choline binding proteins. With this analysis, the liganded and apo biosensor 
structures are separated into two groups (Figure 8a) with the main difference in component 1, which 
accounts for the Venus-flytrap type of conformational change and this conformational change is best 
represented by the structural alignment of varenicline bound iNicSnFR3dt and the apo 
iNicSnFR3dtbp (Figure 8b). As seen in the other betaine or choline binding protein structures in the 
Protein Data Bank, the liganded conformations differ little from each other, and the conformational 
change between liganded and unliganded states are also related by the Venus-flytrap mechanism 
(Figure 8c). Component 2 only accounts for a small fraction of the conformational differences 
between the native structures and the genetically optimized biosensor. This small difference is also 
observed in the structural alignment between a choline bound iASnFRdtbp and a choline bound 
Bacillus subtilis with overall RMSD of 1 Å.  
 
In conclusion, we have structurally characterized apo and liganded states for nicotine and 
acetylcholine biosensors that are genetically engineered from the bacterial periplasmic binding 
protein of a choline/betaine ABC transporter system and a circular permutated green fluorescent 
protein. We further showed that the removal of the cpGFP for crystallization purposes had little 
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impact on the open or closed conformation of the biosensor, suggesting that in the intact sensor, 
the presence of cpGFP did not perturb the conformational changes in the PBP domain of the 
biosensor. Analysis of the binding pocket residues revealed that the key residues in forming the 
cation- p interactions with nicotine in iNicSnFR and acetylcholine in iAChSnFR are two tyrosine 
residues, Y65 and Y357. In addition, the binding pockets are filled with aromatic residues that favor 
binding of hydrophobic molecules, with some polar, non-aromatic residues present to form hydrogen 
bonding interactions with the bound ligand. Lastly, principal component analysis with other binding 
proteins revealed similar conformational changes following the Venus-flytrap mechanism of ABC 
transporter periplasmic binding proteins. The structural analysis presented details for the first time 
liganded states of the engineered biosensors for smoking cessation drugs and neurotransmitters, 
revealing the binding specificity of ligands to the biosensor. This work sets the foundation for future 
work on biosensor design and optimization.  
 
5.4 Materials and Methods 
Cloning, protein expression, and purification 
The gene encoding full length biosensor (iNicSnFR3) was previously cloned into a bacterial 
expression vector as described with a N-terminal 6x His tag (Shivange et al. 2019). The removal of 
HA-tag, MYC-tag, and cpGFP were separately carried out with the Q5 Site-Directed Mutagenesis 
Kit (New England Biolabs). All proteins were overexpressed in Escherichia coli BL21-gold (DE3) 
cells (Agilent Technologies) using ZYM-5052 autoinduction media (Studier 2005). Cells were 
collected by centrifugation and stored at -80 ˚C until use. 
 
For purification, frozen cell pellets were resuspended in lysis buffer containing 100 mM NaCl, 20 
mM Tris, pH 7.5, 20 mM imidazole, pH 7.5, 5 mM β-mercaptoethanol (BME), lysozyme, DNase, 
and protease inhibitor tablet. The resuspended cells were lysed by freezing and thawing using liquid 
nitrogen and room temperature water bath for 3 cycles. Unlysed cells and cell debris were removed 
by centrifugation at ~20,000x g for 40 minutes at 4 ˚C. The supernatant was collected and loaded 
onto a prewashed NiNTA column with wash buffer at 4 ˚C. NiNTA wash buffer contains 100 mM 
NaCl, 20 mM Tris, pH 7.5, 30 mM imidazole, pH 7.5, and 5 mM BME. Elution was achieved using 
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the same buffer containing 300 mM imidazole, pH 7.5. The eluted sample was further purified 
by size exclusion chromatography (SEC) using HiLoad 16/60 Superdex 200 in the same buffer 
without imidazole and BME. Peak fractions were collected and concentrated to ~50 mg/ml with 
Amicon Ultra 15 concentrator (Millipore) with 10kDa cutoff. 
 
Crystallization 
For all constructs, initial crystallization screening was carried out with 40 mg/ml protein in the 
presence and absence of 10 mM nicotine or varenicline. iNicSnFR3dt crystallized separately with 
10 mM nicotine and varenicline in PACT premier, condition #96 with 0.2 M sodium malonate 
dibasic monohydrate, 0.1 M Bis-Tris Propane pH 8.5, and 20% polyethylene glycol (PEG) 3,350 at 
20 °C. Crystals of iNicSnFR3dt grew within two weeks of crystallization in a hexagonal rod shape 
with dimensions of ~ 80 µm x 80 µm x 300 µm. Crystals were harvested and cryo-protected in 25% 
ethylene glycol, 0.2 M sodium malonate dibasic monohydrate, 0.1 M BisTrisPropane pH 8.5, and 
20% PEG 3350. Phase information was obtained through soaking with potassium iodide before cryo-
protection. The unliganded iNicSnFR3dt crystallized in Morpheus (Molecular Dimensions), 
condition #92 with 2.5% PEG 1,000, 12.5% PEG 3,350, 12.5% 2-methyl-2,4-pentanediol, 0.02 M 
of each amino acid and 0.1 M MOPS/HEPES-Na, pH 7.5 at 23 °C with no further optimization.  
 
The unliganded iNicSnFR3dtbp crystallized in Index (Hampton Research), condition # 79 with 0.2 
M ammonium acetate, 0.1 M Bis-Tris, pH 6.5, 25% PEG 3,350 at 23 °C. iNicSnFR4dtbp with bound 
varenicline crystallized in Wizard 1 (Molecular Dimensions), condition #1 with 20% PEG 8,000 and 
0.1 M CHES, pH 9.5 and the condition was further optimized with Additive screen (Hampton 
Research) with the final condition containing an additional 10 mM spermidine. The unliganded 
iNicSnFR4dtbp crystallized in Wizard 4 (Molecular Dimensions), condition #39 with 0.1 M 
imidazole, pH 6.5, 3% 2-methyl-2,4-pentanediol, 20% PEG 8,000 at 23 °C with no further 
optimization. These crystals were harvested directly with well solution before flash-freezing in liquid 
nitrogen.  
 
The initial crystallization screening for iAchSnFRdtbp was carried out with 40 mg/ml protein in the 
presence and absence of 10 mM acetylcholine at 23 °C. The acetylcholine and choline bound 
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iAchSnFRdtbp were crystallized in Wizard 1 (Molecular Dimensions), condition #1 with 20% 
PEG 8,000 and 0.1 M CHES, pH 9.5. The unliganded iAchSnFRdtbp crystallized in Wizard 4 
(Molecular Dimensions), condition #21 with 25% PEG 8,000 and 0.1M MIB (malonate, imidazole, 
and boric acid), pH 5.0. The crystals were harvested directly with well solution before flash-freezing 
in liquid nitrogen.  
 
Data collection, data processing and structural determination 
X-ray datasets were collected at Stanford Synchrotron Radiation Laboratory beamline 12-2 and 
Advanced Light Source beamline 5.0.2 using Pilatus 6M detectors. All datasets were processed and 
integrated with XDS (Kabsch 2010) and scaled with Aimless (Winn et al. 2011). For iNicSnFR3dt, 
molecular replacement was carried out using domains of the unliganded structure (PDB ID: 6EFR) 
with Phaser in Phenix (Adams et al. 2010). The experimental phase information of KI-soaked 
crystals of iNicSnFR3dt was obtained with MR-SAD using AutoSol in Phenix (Adams et al. 2010). 
Molecular replacements of the remaining structures were carried out with the refined model of 
iNicSnFR3dt. Iterative refinement and model building cycles for all structures were carried out 
separately with phenix.refine in Phenix (Adams et al. 2010) and Coot (Emsley et al. 2010). 
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5.6 Figures 
 
 
Figure 1. Construct design.  
(a) Full length biosensor. (b) Biosensors with epitope tags removed. (c) PBP domain-only constructs. 
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Figure 2. Nicotine bound structure of iNicSnFR3dt.  
(a) Overall conformation of iNicSnFR3dt with an electron density blob at the nicotine binding site. 
(b) iNicSnFR3dt binding site residues. (c) Possible cis and trans conformers of nicotine. 
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Figure 3. Varenicline bound structure of iNicSnFR3dt.  
(a) Overall conformation of iNicSnFR3dt with varenicline bound. (b) iNicSnFR3dt binding site with 
varenicline present.  
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Figure 4. Apo structure of iNicSnFR3dt.  
(a) Overall conformation of the apo iNicSnFR3dt. (b) Structural alignment of iNicSnFR3dt in apo 
and varenicline bound conformations. The arrow represents the conformational change of the top 
lobe, resembling the Venus-flytrap mechanism. (c) Orientation differences of E78 in liganded and 
apo structures of iNicSnFR3dt. 
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Figure 5. Structures of PBP domains of iNicSnFR and iAChSnFR.  
(a) iNicSnFR3dtbp in the apo conformation. (b) iNicSnFR4dtbp in the apo conformation. c) 
iNicSnFR3dtbp in the varenicline bound conformation. (d) iAChSnFRdtbp in the choline bound 
conformation. (e) iAChSnFRdtbp in the acetylcholine bound conformation. (f) iAChSnFRdtbp in 
the apo conformation. 
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Figure 6. Structural alignments of iNicSnFR and iAChSnFR.  
(a) Structural alignments of the liganded PBP domain structures of iNicSnFR3, iNicSnFR4, and 
iAChSnFR to the varenicline bound conformation of iNicSnFR3dt. (b) Structural alignments of the 
apo PBP domain structures of iNicSnFR3, iNicSnFR4, and iAChSnFR to the apo conformation of 
iNicSnFR3dt. 
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Figure 7. Binding pocket residues.  
Ligand binding pocket residues in (a) iNicSnFR3dt with varenicline bound, (b) iNicSnFR4dtbp with 
varenicline bound, and (c) iAChSnFR3dt with acetylcholine bound. 
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Figure 8. Principal component analysis.  
(a) Principal component analysis of the available structures of the biosensors and other 
betaine/choline binding protein structures in the Protein Data Bank. Component 1 accounts for 75% 
and component 2 accounts for 17% of total conformational change. Structural alignment of (b) the 
varenicline bound iNicSnFR3dt and apo iNicSnFR3dtbp conformation, (c) the apo structure (PDB 
ID: 3PPN) to the carnitine bound structure (PDB ID: 3PPO) of OpuCC, and (d) the choline bound 
iAchSnFRdtbp to the choline bound OpuCC (PDB ID: 3PPQ). The PDB IDs for the structures 
published in the Protein Data Bank are labeled in the figure.  
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5.7 Tables 
 
Table 1. Data collection and refinement statistics for iNicSnFR3dt with nicotine bound  
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Table 2. Data collection and refinement statistics for iNicSnFR3dt with varenicline bound  
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Table 3. Data collection and refinement statistics for iNicSnFR3dt apo structure 
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Table 4. Data collection and refinement statistics for iNicSnFR3dtbp apo structure 
 
  
 
 
158 
Table 5. Data collection and refinement statistics for iNicSnFR4dtbp with varenicline 
bound  
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Table 6. Data collection and refinement statistics for iNicSnFR4dtbp apo structure 
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Table 7. Data collection and refinement statistics for iAChSnFRdtbp with choline bound  
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Table 8. Data collection and refinement statistics for iAChSnFRdtbp with acetylcholine 
bound  
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Table 9. Data collection and refinement statistics for iAChSnFRdtbp apo structure 
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A p p e n d i x  
METHODS 
6.1 NaAtm1 Purification 
Two different methods were used for NaAtm1 purification; a flowchart of the two methods is shown 
in Figure 1. The first method involves membrane isolation. To isolate the membrane fraction, cells 
were first homogenized in lysis buffer to a final concentration of 0.1g cells per ml, with the lysis 
buffer containing 100 mM NaCl, 20 mM Tris pH7.5, DNase, lysozyme, and protease inhibitor. The 
cells were lysed with a microfluidizer with three passages. The lysate was spun down at ~10,000x g 
at 4˚C to remove cell debris and unlysed cells. The supernatant was taken and ultracentrifuged at 
~125,000x g for an hour to isolate the membrane. The resulting supernatant was discarded, and the 
membrane pellet was washed with cold buffer containing 100 mM NaCl and 20 mM Tris, pH 7.5. 
The membrane pellet was resuspended in the same buffer to a final concentration of 100 mg 
membrane per ml. To store the membrane, aliquots of the resuspended membrane could be flash-
frozen in liquid nitrogen and stored at -80 °C. For purification, the membrane could also further be 
solubilized with 1% detergent (final concentration) with stirring at 4˚ for an hour before 
ultracentrifugation again at ~113,000x g to remove the unsolubilized membrane. This supernatant 
from ultracentrifugation was subsequently loaded onto a pre-wash NiNTA column with 100 mM 
NaCl, 20 mM Tris, pH 7.5, 50 mM imidazole, pH 7.5 and 0.1% detergent. Elution was carried out 
with the same buffer containing 350 mM imidazole, pH 7.5. The eluent was then directly loaded 
onto HiLoad Superdex 200 16/60 (GE Healthcare) for gel filtration chromatography. Peak fractions 
were collected and concentrated with Amicon concentrator (EMD Millipore) with 100 kDa cutoff to 
~20 mg/ml.  
 
The second method involves lysis through detergent solubilization. 1% detergent was directly added 
to the resuspended cells in lysis buffer along with DNase, lysozyme, and protease inhibitor. The 
mixture was then stirred at 4˚C for three hours to solubilize the cells. The lysate was spun down at 
~113,000x g at 4˚C to remove the unlysed cells and cell debris. The supernatant was then purified 
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with NiNTA and gel filtration chromatography as described earlier. One point worth noting in 
this method is the choice of detergent. Not all detergents will solubilize the cells well.  
 
6.2 Disulfide Crosslinking 
Disulfide crosslinks were separately introduced near the Walker-B motif as described in Chapter 2. 
As the native NaAtm1 is cysteine-less, no reducing agent was used during purification. The 
crosslinking variants were all handled in the presence of reducing agent until crosslinking. Briefly, 
the cells were solubilized in lysis buffer containing 100 mM NaCl, 20 mM Tris pH7.5, DNase, 
lysozyme, protease inhibitor, 5 mM b-mercaptoethanol (BME), 0.5% n-dodecyl-b-D-
maltopyranoside (DDM), and 0.5% octaethylene glycol monododecyl ether (C12E8) with stirring at 
4˚C for three hours. The unlysed cells and cell debris were removed by ultracentrifugation at 
~113,000x g. The supernatant was loaded onto a pre-wash NiNTA column with 100 mM NaCl, 20 
mM Tris, pH 7.5, 50 mM imidazole, pH 7.5, 5 mM BME, 0.05% DDM, and 0.05% C12E8 and 
eluted with the same buffer containing 350 mM imidazole, pH 7.5 instead. The eluent was then 
subjected to desalting into 100 mM NaCl, 20 mM Tris, pH 7.5, 0.05% of DDM, and 0.05% C12E8. 
The desalted protein was then crosslinked with 1 mM Cu (II) (1,10-phenanthroline)3 for an hour at 
4˚C. The crosslinked sample was again desalted into the same buffer to remove the oxidant. The 
desalted sample was then concentrated and subjected to gel filtration chromatography with HiLoad 
Superdex 200 16/60 (GE Healthcare). 
 
During the process of disulfide crosslinking optimization, we tried to improve the crosslinking 
efficiency by using different oxidants, altering the reaction pH, changing the reaction temperature, 
adding of nucleotides and/or substrates, and introducing bulky side-chain mutations or other 
functional (substrate and/or ATP binding) mutants, yet none of them seem to improve the 
crosslinking yield significantly. We further tried to separate the crosslinked and uncrosslinked 
products by affinity purification, ion exchange, and size exclusion chromatography, but due to the 
small molecular differences between the two populations, none of the above methods were able to 
separate the two populations. We further saw that the use of different detergent and detergent 
combinations would also affect the crosslinking efficiency (Figure 2), the presence of the two 
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populations was clearly shown in the denaturing SDS-PAGE and the non-denaturing BN (blue 
native)-PAGE (Figure 2).  
 
6.3 Small Scale Detergent Screen 
For NaAtm1 detergent screen, nine different detergents from different detergent classes were chosen, 
including n-dodecyl-b-D-maltopyranoside (DDM), n-decyl-b-D-maltopyranoside (DM), n-nonyl-b-
D-glucopyranoside (NG), n-octyl-b-D-glucopyranoside (OG), 5-cyclohexyl-1-pentyl-b-D-
maltopyranoside (Cymal5), n-dodecyl-N,N-dimethylglycine (DDMG), octaethylene glycol 
monododecyl ether (C12E8), 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-
propanesulfonate (CHAPSO), and n-dodecylphoscholine (FC12). All detergent solutions were 
prepared at 10% (w/v), and made into detergent mixtures with two, three, or four components to a 
final concentration of 10% using equivalent amounts of individual detergents (Table 1). 95 detergent 
mixtures were made and combined with a previously used detergent mixture (CHAPSO, OG, 
LDAO, and HEGA11) (Lee et al. 2014) into a detergent screen in 96-block format. The subsequent 
experiments were all done in a 96-well block format. The isolated membrane (90 µl of stock at 100 
mg membrane/ml) was solubilized with 1% detergent (10 µl of 10% stock in 96-well block) for an 
hour at 4˚C. The solubilized sample was then ultracentrifuged at ~192,000x g to remove the 
unsolubilized membrane. The supernatants were taken and prepared for SDS-PAGE. The results 
from this detergent extraction test were scored on a 0 to 3 scoring system (Figure 3a). 
 
In a separate setting, the 96-well block was subjected to centrifugation at ~1,500x g to remove the 
cell debris. The supernatants were directly loaded onto a pre-washed NiNTA resin with buffer 
containing 100 mM NaCl, 20 mM Tris, pH 7.5, 50 mM imidazole, pH 7.5, and 0.1% detergent. The 
resin was washed with 10x column volumes of the same buffer and eluted with 3 column volumes 
of the same buffer containing 350 mM imidazole, pH 7.5 instead. The eluents were collected and 
ultracentrifuged at ~192,000x g. The supernatants were then subjected to dynamic light scattering to 
check monodispersity. Samples of the NiNTA eluents and supernatants were both analyzed by 
running on SDS-PAGE to check for sample quality. The results from this small scale NiNTA test 
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were then scored on a 1 to 3 scoring system (Figure 3b). As a starting point for crystallization, 
the detergents or detergent mixtures with the highest total score were used to extract and purify 
NaAtm1 (Figure 3c). 
 
6.4 Enzymatic ATPase Assay 
In addition to the colorimetric ATPase activity assays described in Chapter 2 and 3, the ATPase 
activities of NaAtm1 were measured using an enzymatic quantification method. Limitations of this 
method include its non-applicability to proteoliposomes samples due to the scattering of 
proteoliposomes and its non-equimolar concentrations of Mg2+ and ATP in the initial reactions. The 
ATPase activity data obtained using this method was not used in any publication.  
 
In this method, the ATPase activity was determined by measuring the amount of free phosphate 
generated upon ATP hydrolysis with the EnzCheck Phosphatase Assay kit (ThermoFisher Scientific) 
in a 96-well plate format by following the previous protocol (Lee et al. 2014). All reactions were 
done in 100 µL scale using 1 mg protein per reaction in 100 mM NaCl, 20 mM Tris, pH 7.5, 5 mM 
EDTA, and 0.3% w/v CHAPSO at various concentrations of ATP, pH 7.5. The reactions were 
initiated by the addition of 10 mM final concentration of MgCl2. Reactions were done in triplicates, 
and monitored for 40-60 minutes, and the final linear rates obtained from the early timepoints were 
fitted with nonlinear least squares fit using Prism 8. This enzymatic assay was performed for all the 
cysteine crosslinking variants (NaA527C, NaS526C, and NaT525C), the ATP hydrolysis deficient 
variant NaE523Q, and the wild type protein NaAtm1 in detergent (Figure 4).  
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6.5 Figures 
 
 
Figure 1. Membrane protein purification.  
Schematic showing the two main membrane purification protocols used for NaAtm1 with method 
1) involving membrane isolation, and method 2) involving lysis through solubilization using 
detergent.  
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Figure 2. Polyacrylamide gel electrophoresis.  
Top: SDS-PAGE showing disulfide crosslinking of different variants, purified in different detergent 
combinations. Bottom: BN-PAGE showing the crosslinked and uncrosslinked population with 
different migration features. (Note: presence of LDAO has effects on sample migration in BN-
PAGE). 
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Figure 3. Small scale detergent extraction.  
Extraction with 96 detergent mixtures from Table 1. Each lane is labeled with the corresponding 
well number with “nc” standing for negative control with ddH2O addition for extraction instead of 
detergent. 
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Figure 4. Enzymatic ATPase assay.  
ATPase activities measured for (a) NaA527C, (b) NaS526C, and (a) NaT525C in crosslinked protein 
during purification (ox), reduced protein after purification (red), and the reduced protein with 
addition reducing agent (red + DTT (dithiothreitol)). (d) NaAtm1 and NaE523Q ATPase activities 
in the presence and absence of DTT as both constructs do not have cysteines.  
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6.6 Tables 
 
Table 1. Detergent screen composition.  
The screen was made from nine different individual detergents. The different detergent mixtures 
contain equal amounts of each detergent component, with a total concentration of 10% (w/v). The 
numbers (1-9) in the block represent individual detergents shown below the table.  
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Table 2. Small scale detergent screen results.  
(a) Manually scored small scale extraction results on a 0-3 scoring system, with 3 representing good, 
2 representing ok, 1 representing bad, and 0 representing terrible extractions. (b) Manually scored 
small scale NiNTA purification results on a 1-3 scoring system, with 3 representing good, 2 
representing ok, and 1 representing bad. (c) Total scores from both tests, shown in (a) and (b). 
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